Method and apparatus for determining meal start and peak events in analyte monitoring systems

Information

  • Patent Grant
  • 11717225
  • Patent Number
    11,717,225
  • Date Filed
    Wednesday, December 4, 2019
    5 years ago
  • Date Issued
    Tuesday, August 8, 2023
    a year ago
Abstract
Systems, methods and apparatus are provided for estimating meal start and peak meal response times are provided based on time series of sampled glucose data collected. Numerous additional aspects are disclosed.
Description
BACKGROUND

The detection of the concentration level of glucose or other analytes in certain individuals may be vitally important to their health. For example, the monitoring of glucose levels is particularly important to individuals with diabetes or pre-diabetes. People with diabetes may need to monitor their glucose levels to determine when medication (e.g., insulin) is needed to reduce their glucose levels or when additional glucose is needed.


Devices have been developed for automated in vivo monitoring of analyte time series characteristics, such as glucose levels, in bodily fluids such as in the blood stream or in interstitial fluid. Some of these analyte level measuring devices are configured so that at least a portion of a sensor of an on-body device is positioned below a skin surface of a user, e.g., in a blood vessel or in the subcutaneous tissue of a user. As used herein, the term analyte monitoring system is used to refer to any type of in vivo monitoring system that uses a sensor disposed with at least a subcutaneous portion to measure and store sensor data representative of analyte concentration levels automatically over time.


Existing approaches to determining pre-prandial and post-prandial meal responses are achieved in several ways. One way to determine the pre-prandial and post-prandial meal responses uses paired fingerstick blood glucose tests, where glucose measurements are taken at the start of the meal and at a certain relative duration since the meal start. In this approach, however, the variability of duration between start and peak of meals results in estimation errors of the meal response. Another approach to determine pre-prandial and post-prandial meal responses uses a collection of dense glucose measurements (e.g. once every 10 minutes) in conjunction with user entered meal markers. However, as most meal markers only indicate the start of the meal, the availability and accuracy of such markers are affected by the patient's schedule and other unforeseeable circumstances. Yet another approach to determining pre-prandial and post-prandial meal responses includes collection of dense glucose measurement and a pre-determined time of day window, where glucose values within a particular time of day window are assumed to represent pre-breakfast, post-breakfast, for example. However, in this approach, the reliability of the estimates will largely depend upon the consistency in the patient's meal timing routine.


SUMMARY

Accordingly, embodiments of the present disclosure provide systems, methods, and apparatus for estimating or detecting start of meal event and peak meal response based on real time or pseudo-retrospective, or retrospective analysis of data corresponding to monitored analyte levels, which can be used to modify insulin therapy regimen such as adjusting the basal delivery rate for pump users, and/or adjusting bolus dose levels.


Certain embodiments of the present disclosure include performing conditioning on a plurality of data points corresponding to monitored analyte level over a first time period, for each data point, determining a time derivative based on the conditioned plurality of data points, determining optima of acceleration based on the determined time derivatives, removing false carbohydrate intake start and peak carbohydrate intake response pairs having an amplitude below a predetermined level, removing carbohydrate intake start candidate from the most current carbohydrate intake peak response candidate, removing unpaired carbohydrate intake start candidates and signal artifact falsely identified as carbohydrate intake start and carbohydrate intake peak response pair, and refining the identified carbohydrate intake start and peak carbohydrate intake response pairs.


Certain embodiments of the present disclosure include a user interface component and one or more processors operatively coupled to the user interface component, the one or more processors configured to perform conditioning on a plurality of data points corresponding to monitored analyte level over a first time period, for each data point, to determine a time derivative based on the conditioned plurality of data points, to determine optima of acceleration based on the determined time derivatives, to remove false carbohydrate intake start and peak carbohydrate intake response pairs having an amplitude below a predetermined level, to remove carbohydrate intake start candidate from the most current carbohydrate intake peak response candidate, to remove unpaired carbohydrate intake start candidates and signal artifact falsely identified as carbohydrate intake start and carbohydrate intake peak response pair, and to remove the identified carbohydrate intake start and peak carbohydrate intake response pairs.


Numerous other aspects and embodiments are provided. Other features and aspects of the present disclosure will become more fully apparent from the following detailed description, the appended claims, and the accompanying drawings.





BRIEF DESCRIPTION OF THE FIGURES

The accompanying drawings, which are incorporated herein, form part of the specification. Together with this written description, the drawings further serve to explain the principles of, and to enable a person skilled in the relevant arts, to make and use the present disclosure.



FIG. 1 illustrates a flowchart for meal start and peak detection routine in accordance with certain embodiments of the present disclosure;



FIG. 2 illustrates a flowchart for performing time series sampled analyte data conditioning of the meal start and peak detection routine of FIG. 1 in accordance with certain embodiments of the present disclosure;



FIG. 3 illustrates a flowchart for sampled data analysis to remove questionable data of FIG. 2 in accordance with certain embodiments of the present disclosure;



FIG. 4 illustrates a flowchart for data conditioning and/or data recovery for smooth output of FIG. 2 in accordance with certain embodiments of the present disclosure;



FIG. 5 illustrates sample data analysis to remove questionable data and performing condition and/or data recovery for smooth output in conjunction with the routines above in certain embodiments of the present disclosure;



FIG. 6 illustrates data conditioning and/or data recovery for smooth output in conjunction with the routines above in certain embodiments of the present disclosure;



FIG. 7 illustrates determination of backward and forward slopes for peak and meal start candidates in conjunction with the routines above in certain embodiments of the present disclosure;



FIG. 8 illustrates determination of acceleration and the identification of local acceleration optima in conjunction with the routines above in certain embodiments of the present disclosure;



FIG. 9 illustrates an example of removal of adjacent candidates of the same type in conjunction with the routines above in certain embodiments of the present disclosure;



FIG. 10 illustrates examples of removal of false meal start and peak pairs with a small amplitude in conjunction with the routines above in certain embodiments of the present disclosure;



FIG. 11 illustrates removal of unpaired meal start candidates and surviving spike artifacts falsely identified as a meal start/peak pair in conjunction with the routines above in certain embodiments of the present disclosure;



FIG. 12 illustrates refinement of identified meal start and peak instances in conjunction with the routines above in certain embodiments of the present disclosure; and



FIG. 13 illustrates an example of comparison of estimated meal start determination in conjunction with the routines described herein against manually marked meal start events.





DETAILED DESCRIPTION

Before the embodiments of the present disclosure are described, it is to be understood that this disclosure is not limited to the particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the embodiments of the disclosure will be limited only by the appended claims.


The present disclosure provides systems, methods, and apparatus to determine meal start and peak events based on analysis of information associated with monitored analyte concentration level. According to embodiments of the present disclosure, a dataset representative of a patient's monitored analyte concentration level (herein referred to as “sensor data”) over time is received from an on-body device that includes sensor electronics operatively coupled to an analyte sensor that is in fluid contact with interstitial fluid. In some embodiments, the sensor data may represent a collection of data received from the on-body device at several different times during a wear period of the on-body device. In some other embodiments, the sensor data may represent data collected and stored over an entire wear period of the on-body device and only received from the on-body device at the end of the wear period or at the end of the useful life of the on-body device. In other words, the sensor data can be transmitted continuously, on a regular schedule, in multiple batches over time, in batches on demand, or in a single batch.


Embodiments of the present disclosure may be applied to any analyte concentration level determination system that may exhibit or at least be suspected of exhibiting, or that may be susceptible to noise in the sensor data. Embodiments of the disclosure are described primarily with respect to continuous glucose monitoring devices and systems but the present disclosure may be applied to other analytes and analyte characteristics, as well as data from measurement systems that transmit sensor data from a sensor unit to another unit such as a processing or display unit in response to a request from the other unit. For example, other analytes that may be monitored include, but are not limited to, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be monitored. In the embodiments that monitor more than one analyte, the analytes may be monitored at the same or different times. The present disclosure also provides numerous additional embodiments.


Embodiments of the present disclosure may include a programmed computer system adapted to receive and store data from an analyte monitoring system. The computer system may include one or more processors for executing instructions or programs that implement the methods described herein. The computer system may include memory and persistent storage devices to store and manipulate the instructions and sensor data received from the analyte monitoring system. The computer system may also include communications facilities (e.g., wireless and/or wired) to enable transfer of the sensor data from the analyte monitoring system to the computer. The computer system may include a display and/or output devices for identifying dropouts in the sensor data to a user. The computer system may include input devices and various other components (e.g., power supply, operating system, clock, etc.) that are typically found in a conventional computer system. In some embodiments, the computer system may be integral to the analyte monitoring system. For example, the computer system may be embodied as a handheld or portable receiver unit within the analyte monitoring system.


Embodiments of the present disclosure perform analysis on analyte (e.g., glucose) data collected from analyte monitoring systems that includes a combination of asynchronous real-time and time spaced (e.g., 5 minutes-, 10 minutes-, 15 minutes-, 20 minutes-, 30 minutes-apart historical glucose data such as in flash glucose monitoring (FGM) systems, to be processed for analyte pattern and titration analysis. Embodiments also include analysis of mixed data collected from any of the following systems: discrete blood glucose monitoring (DGM) systems, continuous glucose monitoring (CGM) systems, in addition to flash glucose monitoring (FGM) systems. In this manner, embodiments of the present disclosure provide improved reliability of glucose pattern and titration analysis by distinguishing between true glucose trends and measurement errors, artifacts, and gaps caused by the measurement timing and/or process.


Prior approaches took pre-defined windows of time (e.g. entire 14 day sensor data collected, or 24 hours) to calculate glucose variability and median glucose. Such an approach analyzed each glucose reading independently, regardless of the relative timing and physiological feasibility of the relative magnitudes of glucose values. On the other hand, embodiments of the present disclosure perform physiological feasibility checks by comparing analyte level readings that are spaced close in time to obtain a more reliable estimate of glucose values.


Embodiments of the present disclosure includes first identifying and removing questionable data, where physiological limits are used to compare each measurement in the context of other nearby measurements, and thereafter, performing data conditioning and recovery including, for example, where surviving sampled data are conditioned, by signal processing, to minimize the amount of noise as much as possible, and the removed sampled data are supplemented by data based on other sampled data in close proximity to it in time. For example, performing data conditioning and recovery procedure includes data analysis routines described in pending U.S. patent application Ser. No. 14/210,312 entitled “Noise rejection Methods and Apparatus for Sparsely Sampled Analyte Sensor Data” filed on Mar. 13, 2014, the disclosure of which is incorporated herein by reference for all purposes.


Embodiments of the present disclosure include estimating the start time and peak instances of meal events based on sampled analyte data such as glucose measurement data, which can be used to improve the reliability of existing start-of-meal markers manually entered by the user.


In certain embodiments, the following assumptions are made when the algorithm performs data processing to determine the start and the peak of a meal event. For example, it is assumed that each meal event is far enough apart in time such that the initial change in glucose rise and the subsequent reversal is discernible from signal artifacts that may exist in the available sensor data measurements. Furthermore, the interaction between a meal and insulin is such that insulin cannot perfectly cancel the change in glucose due to the meal. This excludes clamps where both dextrose and insulin are intravenously administered at near constant infusion rates. Also, a meal may have insufficient insulin bolus, which would result in a higher post prandial glucose level than the pre-prandial glucose level, and may still continue to rise afterwards. In other words, the glucose response looks like the superposition of an increasing ramp and a textbook meal response (i.e. starting at a certain value, rising rapidly at the start of the meal, and decreasing at a slightly slower rate than the rate of increase). Accordingly, in certain embodiments, the glucose data are screened for local acceleration optima (ie. minima or maxima) as the initial candidate, and further refines the candidate start and peak instances by eliminating false candidates and adjusting the position of the final set of candidates.



FIG. 1 illustrates a flowchart for meal start and peak detection routine in accordance with certain embodiments of the present disclosure. Referring to FIG. 1, sampled analyte (e.g. glucose) data from analyte monitoring systems or devices are collected or received and time series data conditioning is performed (110) that includes, for example, data conditioning to remove questionable readings from the sampled data and smoothing out the final result as described in detail below in conjunction with FIGS. 2-4. In certain embodiments, the data conditioning results in generating regularly spaced glucose values from irregularly sampled data. In certain embodiments, data conditioning includes determining whether sampled glucose data may be outliers when compared to sampled glucose data that are temporally in close proximity with each other. FIG. 6 illustrates data conditioning and/or data recovery for smooth output in conjunction with the routines above in certain embodiments of the present disclosure.


Referring to FIG. 1, after performing time series data conditioning (110), for each sampled sensor data, a set of slopes for the sampled analyte data are determined (120). That is, for each sampled data, a set of time derivatives in each time instance k of the glucose time series is determined (120). Separate sets of slopes or time derivatives are calculated to determine peak and meal start candidates. The selection of the time window duration where these sets of time derivatives are to be determined from, in the order of a few hours, are tuned to detect meal responses and ignore transients and other unrelated elements of glucose time series progression. The number of sampled data involved depends on the relative timestamps associated with when the sampled data was acquired.


More specifically, in certain embodiments, the set of slopes for determining a peak candidate, is a pair of slopes; one generated by computing rate of change in a forward window, and another generated by computing rate of change in a backward time window. Specifically, in certain embodiments, determining the forward and backward time window rates of change for the peak candidate includes using the sampled glucose data that are in the forward time window (i.e. from the present measurement at k to its near future time instance, such as 2˜3 hours later) for the peak candidate, and then fit a straight line using Least-Squares error (LS) fit method. The slope is the forward rate of change for the peak candidate, v_peak_fwd(k). Further, determining the backward window rate includes using sampled glucose data that are in the backward window (i.e. from the present measurement at k to its near past time instance, such as 1˜2 hours prior) for the peak candidate, and then fit a straight line using Least-Squares error (LS) fit method. The slope is the backward rate of change for the peak candidate, v_peak_bck(k).


In addition, the set of slopes for determining a meal start candidate is a pair of slopes; one generated by computing rate of change in a forward window, and another generated by computing rate of change in a backward time window. More specifically, in certain embodiments, determining forward and backward window rates of change for the meal start candidate includes using the sampled glucose data that are in the forward window (i.e. from the present measurement at k to its near future time instance, such as 1˜1.5 hours later) for the meal start candidate, and then fit a straight line using Least-Squares error (LS) fit method. The slope is the forward rate of change for the meal start candidate, v_start_fwd(k). In certain embodiments, the forward window for peak and meal start candidates does not necessarily have the same width. Further, determining the backward window rate includes using sampled glucose data that are in the backward window (i.e. from the present measurement at k to its near past time instance, such as 2˜3 hours prior) for the meal start candidate, and then fit a straight line using Least-Squares error (LS) fit method. The slope is the backward rate of change for the meal start candidate, v_start_bck(k). In certain embodiments, the backward window for peak and meal start candidates does not necessarily have the same width.


Referring to FIG. 1, the slope determination or determination of time derivatives for sampled data in the time series data (120) in certain embodiments includes determining the acceleration for the peak candidate, a_peak(k), where the acceleration for the peak candidate, a_peak(k), is defined as (v_peak_fwd(k)-v_peak_bck(k))/T_peak, where T_peak is a pre-determined sample period scaling factor for the peak candidate determination (for example, 1˜3 hours).


Further, the slope determination or determination of time derivatives for sampled data in the time series data (120) further includes determining the acceleration for the start candidate, a_start(k), where acceleration for the start candidate, a_start(k) is defined as (v_start_fwd(k)-v_start_bck(k))/T_start, where T_start is a pre-determined sample period scaling factor for the meal start candidate determination (for example, 1˜3 hours).


In this manner, in certain embodiments, the determination of time derivatives for sampled data in the time series data (120) includes slope or rate of change determination for each instance k of the sampled data, as shown for example, in FIG. 7. More specifically, FIG. 7 illustrates determination of backward and forward slopes for peak and meal start candidates in conjunction with the routines above in certain embodiments of the present disclosure. Referring to FIG. 7, circled sampled glucose data measurement instance and the nearby arrows illustrate the approximate size of the forward (to the right of the measurement instance) and backward (to the left of the measurement instance) time windows for the slope determinations.


Referring back to FIG. 1, after the determination of time derivatives for sampled data in the time series data (120), the local optima of acceleration is determined (130). More specifically, in certain embodiments, the local optima of acceleration are identified based upon signal analysis to identify extreme bend points. More specifically, in certain embodiments, at each time instance k, the determined acceleration for the peak candidate, a_peak, that falls within the forward window (incorporating data from present to 1˜2 hrs later) for the peak candidate is determined, with the exception of the value at time instance k, a_peak(k). Further, at each time instance k, value a_peak that falls within the backward window (incorporating data from 1˜2 hrs before to the present) for the peak candidate is determined, with the exception of the value at time instance k, a_peak(k). If the value a_peak(k) is less than or equal to the minimum a_peak values in the two aforementioned windows, the current time instance k is determined as a peak candidate during the determination of local optima of acceleration (130).


At each time instance k, the determined acceleration for the meal start candidate, a_start, that falls within the forward window (incorporating data from present to 1˜2 hrs later) for the meal start candidate is determined, with the exception of the value at time instance k, a_start(k). At each time instance k, value a_start that falls within the backward window (incorporating data from 1˜2 hrs before to the present) for the meal start candidate is determined, with the exception of the value at time instance k, a_start(k). If the value a_start(k) is greater than or equal to the maximum a_start values in the two aforementioned windows, then the current time instance k is determined as a meal start candidate during the determination of local optima of acceleration (130). In certain embodiments, if a time instance k has been previously identified as a peak candidate, and is also identified as a meal start candidate, the meal start candidate tag is moved to the next instance k+1. FIG. 8 illustrates determination of acceleration and the identification of local acceleration optima in conjunction with the routines above in certain embodiments of the present disclosure. More specifically, FIG. 8 illustrates the identification of the peak and meal start candidates described above and as marked by up and down triangles on the acceleration plot of FIG. 8.


More specifically, in certain embodiments, from all instances k of sampled glucose data in a time series, an initial subset of data is generated that includes all instances, m, identified or tagged as either a peak or meal start candidate from local optima of acceleration determination (130). For example, from each sampled glucose measurement instance k=1, 2, 3, . . . 10000, of 10000 measurement points, 5 candidates are identified from instances k=100, 150, 300, 400, and 700. The 5 candidate instances m=1, 2, 3, 4, 5, would be associated with the original instances as follows: the first candidate instance m=1 corresponds to the original instance at k=100, and the 2nd candidate instance m=2 corresponds to the original instance at k=150, etc.


Referring back to FIG. 1, after the determination of local optima of acceleration (130), data analysis continues to identify and remove false meal start and peak candidates. In a first stage of analysis and removal, adjacent candidates of the same type are removed (140). That is, since a meal start event cannot be adjacent in time to another meal start event, and similarly, a peak meal response event cannot be adjacent in time to another peak meal response event, during the first stage of analysis and removal, adjacent candidates of the same type are identified and removed from the data set under consideration.


More specifically, from the initial subset of data including all instances, m, a first stage list of peak and meal start candidates identified as adjacent candidates of the same type is generated. From this first stage list, peak candidates are removed because the next instance of an adjacent peak candidate has a larger glucose value. That is, a peak candidate is removed during the first stage based on the following criteria: (1) the next instance m+1 in the subset is also a peak candidate; (2) the next instance m+1 in the initial subset has a larger glucose value than the current instance m; and (3) the rate from the forward peak calculation of the current instance m, v_peak_fwd(m), is more than a non-negative noise floor v_min_rise (e.g. 0.5 mg/dL/min). Calculated rates of change whose absolute numbers are close to zero tend to contain a lot of noise. Additionally, in certain embodiments, a peak candidate is also removed during the first stage if the prior instance of an adjacent peak candidate has a larger glucose value, i.e., based on the following criteria: (1) the previous instance m−1 in the initial subset is also a peak candidate; and (2) previous instance m−1 in the initial subset has a larger glucose value than the current instance m.


Furthermore, in certain embodiments, from the first stage list, meal start candidates are removed because the previous instance of an adjacent meal start candidate has a smaller glucose value. That is, a meal start candidate is removed during the first stage based on the following criteria: (1) the previous instance m−1 in the initial subset is also a meal start candidate; (2) the previous instance m−1 in the initial subset has a smaller glucose value than the current instance m; and (3) the value a_start(m−1) is smaller than a_start(m). In addition, in certain embodiments, a meal start candidate is also removed during the first stage if the next instance of an adjacent meal start candidate has an equal or smaller glucose value, i.e., based on the following criteria: (1) the next instance m+1 in the initial subset is also a meal start candidate; and (2) the next instance m+1 has a glucose value that is either equal to or less than the glucose value than the current instance m.


In this manner, in certain embodiments, adjacent meal start candidate or peak candidates of the same type are identified and removed from the data set under consideration. FIG. 9 illustrates an example of removal of adjacent candidates of the same type in conjunction with the routines above in certain embodiments of the present disclosure. More specifically, FIG. 9 is an example illustration of a meal start candidate at around 1.9 days that was identified during the local optima of acceleration determination (130), but was removed during the first stage of analysis and removal based on analysis determining the meal start candidate as adjacent candidate of the same type (140).


Referring again to FIG. 1, after removing adjacent candidates of the same type (140), the routine continues with a second stage of analysis and removal to identify and remove false meal start/peak pairs with small amplitude change (150). More specifically, in certain embodiments, an analysis is performed on the subset of remaining instances of peak candidates and meal start candidates following the first stage of removal based on adjacent candidates of the same type, i.e., a first stage subset. During the second stage, every peak candidate in the first stage subset is analyzed to determine whether the change in glucose value from the previous instance m−1, which would be a meal start candidate, to the current peak candidate m is sufficiently large. In other words, the current peak candidate m is removed from the first stage subset of tagged start or peak candidates when the following criteria are met: (1) previous instance m−1 in the first stage subset (after removal of adjacent candidates of the same type) is tagged as a meal start candidate; (2) the current instance m in the first stage subset is tagged as a peak candidate; and (3) the difference between the amplitude of the current instance m and the previous instance m−1 is less than or equal to g_min_amplitude, i.e. g(m)−g(m−1)<=g_min_amplitude, wherein g is the instance amplitude or level of glucose. Moreover, in certain embodiments, when a peak candidate is removed under these conditions, the corresponding meal start candidate, that is the previous instance m−1, is also removed.


By way of an example, FIG. 9 illustrates examples of removal of false meal start and peak candidate pairs with a small amplitude change in conjunction with the routines above in certain embodiments of the present disclosure. More specifically, FIG. 9 illustrates 2 pairs (around 1.8 days and 1.95 days) that were removed based on the analysis described herein to remove false meal start/peak pairs with small amplitude change.


Referring still to FIG. 1, after identifying and removing false meal start/peak pairs with small amplitude change (150), the routine continues with a third stage of analysis and removal to identify and remove false meal start candidates based on proximity and level drop from the most recent last peak candidate (160). That is, in certain embodiments, meal start candidates that are too close in time to a prior peak candidate and whose glucose value is not significantly lower than the glucose value of its prior peak candidate, are removed from the subset of remaining instances of peak candidates and meal start candidates following the second stage of removal, i.e., a second stage subset.


More specifically, in certain embodiments, during the third stage, it is determined whether the position of each meal start candidate with respect to a previous peak candidate is reasonable. That is, a meal start candidate at instance m is removed when the following criteria are met: (1) the previous instance m−1 in the second stage subset (after removal of start/peak pair with small amplitude change) is tagged as a peak candidate (e.g. see up triangle at around 6.975 days in FIG. 10); (2) the current instance m in the second stage subset is identified or tagged as a meal start candidate (e.g. see down triangle at around 7 days in FIG. 10); (3) the next instance m+1 in the second stage subset is identified or tagged as a peak candidate (e.g. see up triangle at around 7.04 days in FIG. 10); (4) the average value of v_start_bck(m) (see down triangle at around 7 days of FIG. 10) and v_peak_fwd(m−1) (see up triangle at around 6.975 days of FIG. 10) is greater than a maximum post-prandial recovery descent rate, v_max_descent (e.g. ¼ mg/dL/min); and (5) the difference between the glucose value of the current instance m and the previous instance m−1, g(m)−g(m−1), is less than or equal to a minimum required drop from a previous peak, g_min_drop (e.g. 5˜10 mg/dL). Moreover, when these criteria are met and a meal start candidate is removed, the peak candidate at the previous instance m−1, is also removed. FIG. 10 illustrates a meal start candidate at around 7 days that was removed, along with the prior peak candidate, due to proximity and level drop.


Referring again to FIG. 1, after removing meal start candidates based on proximity and level drop from the most recent last peak candidate (160), the routine continues, in certain embodiments, with a fourth stage of analysis and removal to identify and remove unpaired meal start candidates and surviving spike artifacts falsely identified as meal start/peak pairs (170). Surviving spike artifacts might happen if Time Series Data Conditioning (110) does not completely remove all artifacts. More specifically, in certain embodiments, surviving spike artifacts falsely identified as meal start/peak pairs, are removed from the subset of remaining instances of peak candidates and meal start candidates following the third stage of removal, i.e., a third stage subset. For each instance m in the third stage subset that is a start candidate, those whose next instance m+1 is not a peak candidate is removed. That is, a current meal start candidate at instance m is removed from the third stage subset if all of the following applies: (1) the current instance m is tagged as a meal start candidate; (2) the next instance m+1 is tagged as a peak candidate; and (3) the aggregate glucose rate of change, as calculated from g(m+1)−g(m), divided by the time interval between the two instances m+1 and m, is larger than a maximum allowable initial post-prandial rate of change, v_max_initialSpike (e.g. 6 mg/dL/min, which is a rate of change that is likely not sustainable between two candidate points).


Referring to the Figures, FIG. 11 illustrates removal of unpaired meal start candidates and surviving spike artifacts falsely identified as a meal start/peak pair in conjunction with the routines above in certain embodiments of the present disclosure. An example of a start candidate to be removed by this criteria is shown in FIG. 11, at around 5.35 days, where the next instance at around 5.44 days is also a start candidate.


In certain embodiments, because of the asymmetrical forward and backward time windows used to determine the pair v_start_fwd and v_start_bck, as well as the pair v_peak_fwd and v_peak_bck, and since a post-prandial meal response may be followed by a subsequent post-prandial meal response without sufficient time for the original post-prandial meal response to revert to the baseline or fasting glucose levels, the identification of meal start and peak candidate may be visibly biased slightly before or after the likely instance. Accordingly, in certain embodiments, these likely instances are analyzed and adjusted as discussed below.


More specifically, after the four stages of analysis and removal discussed above are complete, the remaining identified meal start and peak candidates are refined (180) in certain embodiments. That is, for each sampled glucose data time instance k, a simple forward and backward slope is determined. For example, all sampled glucose data measurement instances k are evaluated to refine the meal start and peak candidates remaining after the four stages of analysis and removal, identified in the subset of instances m. In certain embodiments, the time window sizes used in determining v_peak_fwd, v_peak_bck, v_start_fwd, v_start_bck, may be larger and asymmetric compared to the determinations steps that follow determining v_peak_fwd, v_peak_bck, v_start_fwd, v_start_bck. In this manner, false candidates due to signal artifacts are rejected earlier on in the routine as described in conjunction with FIG. 1, and by the start of the routine to refine the identified meal start and peak instances (180), the candidates are sufficiently localized to the true meal start and peak. Further, the smaller time windows provide a better precision in the determination.


In particular, for each sampled glucose data at instance k, g(k), an available sample that is as close to 30 minutes prior to k as possible, g_prev(k) is identified. Also, for each sampled glucose data at instance k, g(k), an available sample that is as close to 30 minutes after k as possible, g_after(k) is identified. Then, forward and backward slopes, v_fwd(k) and v_bck(k). v_fwd(k) are determined by taking the difference g_after(k)−g(k), and dividing it by their time interval (around 30 minutes). Also, backward slope v_bck(k) is calculated by taking the difference g(k)−g_prev(k), and dividing it by their time interval. The difference in slope, dv(k), is determined by taking the difference v_fwd(k)−v_bck(k).


For every instance k where a meal start or peak has been identified during removal of start candidates based on proximity and level drop analysis from most recent last peak candidate (160), the time instances in pairs of meal start and peak are identified.


For each identified meal start/peak pair a glucose time series, g_array_start, up to 90 minutes prior to the identified start candidate, and up to 60 minutes after the identified start candidate is defined. The defined glucose time series, g_array_start includes the meal start candidate that survived the data processing (110 to 170) in the routine described above in conjunction with FIG. 1. Also, a glucose time series, g_array_peak, up to 60 minutes prior to the identified peak candidate, and up to 180 minutes after the identified peak candidate is defined. The glucose time series, g_array_peak includes the peak candidate that survived the data processing (110 to 170) in the routine described above in conjunction with FIG. 1. Then, g_array_peak from any sampled glucose data are trimmed whose timestamp overlaps the start time of the next pair in the routine where the unpaired start candidates and surviving spike artifacts falsely identified as meal start/peak pair are removed (170). For each value in g_array_start and g_array_peak, the corresponding difference in slope values, dv are determined from the same instances. Arrays of these values, dv_array_start and dv_array_peak are defined.


Thereafter, in certain embodiments, a subset of time instances are determined such that (1) measured glucose value at these instances are greater than or equal to the 75th percentile of g_array_peak, and (2) dv value at these instances are less than or equal to the 25th percentile of dv_array_peak. If such a subset contains data, then the highest glucose value in this subset, g_max, and its corresponding instance, is stored. Furthermore, the routine determines a subset of time instances such that (1) measured glucose value at these instances are less than or equal to the 25.sup.th percentile of g_array_start, and (2) dv value at these instances are greater than or equal to the 75.sup.th percentile of dv_array_start. If such a subset contains data, then the lowest glucose value in this subset, g_min, and its corresponding instance, is stored. Then the peak and start candidate for this pair with the highest glucose value in the subset, g_max and the lowest glucose value in the subset, g_min, are updated based on the following criteria: (1) the lowest glucose value in the subset, g_min, and the highest glucose value in the subset, g_max, exist and are finite; (2) the instance of lowest glucose value in the subset, g_min, occurs prior to the instance of the highest glucose value in the subset, g_max; and (3) the lowest glucose value in the subset, g_min, is less than the highest glucose value in the subset, g_max.



FIG. 12 illustrates refinement of identified meal start and peak instances in conjunction with the routines above in certain embodiments of the present disclosure. More specifically, FIG. 12 provides an example illustration of the effect of the routine to refine the identified start/peak pairs (180) of FIG. 1 when glucose measurement is sampled at a relatively fast sample period of once every minute. For sparser sample periods (such as illustrated in FIG. 11), the number of sampled glucose data that can be a viable peak or meal start candidates are much smaller than faster sample periods. As a result, the refinement of identified meal start/peak pairs (180) is more useful in certain embodiments, around time periods with a lot of measurements than periods with sparse measurements.



FIG. 13 illustrates an example of comparison of estimated meal start determination in conjunction with the routines described herein against manually marked meal start events. Referring to FIG. 13, there is shown sampled glucose data from a patient, along with patient-recorded meal marker, long acting insulin, and rapid acting insulin. The estimated meal start and peak as described in conjunction with FIG. 1 above is also shown. The plot in FIG. 13 covers approximately one day, starting from a fasting period (up to around 21 hours since glucose sensor start (to acquire sampled glucose data)), followed by a series of meals, and a potentially unrecorded rescue carbohydrate at around hour 41. There are 7 meal markers recorded, two of them within a few minutes at around hour 19. It can be seen from FIG. 13 that the first two meal markers appear to correspond to the increase estimated at around hour 21. The third meal marker may be a late entry from the lunch at hour 24, and the subsequent two entries may be snacks. The two snacks were assumed as a single meal by the estimation routine in accordance with the embodiments of the present disclosure, due to an assumption about minimum duration of meals reflected in the duration of the forward and backward windows of the peak and start candidates during the local optima of acceleration determination. The last two may correspond to the bulk of dinner and a desert, although the glucose response seems to be delayed by about 3 hours.


Referring back to the Figures, FIG. 2 illustrates a flowchart for performing time series sampled analyte data conditioning of the meal start and peak detection routine of FIG. 1 in accordance with certain embodiments of the present disclosure. Referring to FIGS. 1 and 2, performing time series sampled analyte data conditioning of the meal start and peak detection (110) in certain embodiments includes performing sampled data analysis to remove questionable data, where physiological limits are used to compare each sampled glucose data in the context of other temporally closely located sampled glucose data (210). Thereafter, data conditioning and/or recovery is performed to smooth the data output (220), where surviving sampled data are conditioned to minimize noise, and removed measurements are supplemented by sampled data based on other temporally closely located sampled data.



FIG. 3 illustrates a flowchart for sampled data analysis to remove questionable data of FIG. 2 in accordance with certain embodiments of the present disclosure. Referring to FIG. 3, in certain embodiments, removal of questionable sampled glucose data includes data processing and analysis as described below. More specifically, for each sampled data instance, more than one triplet of time windows is defined to address data stream with a range of sample time intervals. That is, a first triplet of left, center, and right time windows ScreenLeft1, ScreenCenter1, and ScreenRight1, respectively, are defined where (1) the left time window only looks at available measurements prior to the current instance (e.g. from 30 minutes ago to 3 minutes ago); (2) the right time window only looks at available measurements after the current instance (e.g. from 3 minutes to 30 minutes after the current instance); (3) the center time window only looks at available measurements slightly before the current instance and slightly after the current instance (e.g. within ±3 minutes of the current instance); and (4) each time window requires a minimum number of available points (e.g. 1 for the center time window, 2 for the left time window, and 2 for the right time window).


Furthermore, a second triplet of left, center, and right time windows ScreenLeft2, ScreenCenter2, and ScreenRight2, respectively are defined, where (1) left time window is narrower than that of ScreenLeft1 (e.g. from 15 minutes ago to 3 minutes ago), but requires a larger number of minimum available points (e.g. 6 points); (2) right time window is narrower than that of ScreenRight1 (e.g. from 3 minutes to 15 minutes after the current instance), but requires a larger number of minimum available points (e.g. 6 points); and (3) center time window requires a larger number of minimum available points (e.g. 4 points). Also, a maximum allowable range ScreenMaxRange and maximum allowable relative range ScreenMaxRelativeRange are defined to be used to compare multiple estimates based on the different time windows.


Referring back to FIG. 3, after defining multiple triplets of data windows for the sampled data (310), data within the multiple triplets of data windows are identified and it is determined whether the identified data meet the minimum number of data points (320). More specifically, for each sampled glucose data instance, measurements that fall within the multiple triplets of windows as set forth above are identified, and it is determined whether or not the number of available points in each time window meets the respective minimum number of points. Then, it is determined whether comparison based on each triplet can be performed (330) based on the following criteria: (1) comparison within the first triplet can be performed when there is sufficient number of measurements in ScreenCenter1, and either there is sufficient number of sampled data in ScreenLeft1 or ScreenRight1; and (2) comparison within the second triplet can be performed when there is sufficient number of measurements in ScreenCenter2, and either there is sufficient number of measurements in ScreenLeft2 or ScreenRight2.


Furthermore, for each sampled glucose data instance, if comparison within the first triplet can be performed the following routines are performed (340). More specifically, yCenter1, an estimate of current measurement instance based on ScreenCenter1, is determined by taking the average of available points in ScreenCenter1, yRight1, an estimate of current measurement instance based on ScreenRight1, is determined by performing a least-square error fit of a straight line using available points in ScreenRight1, evaluated at the instance of the current sampled data. The estimate of current measurement instance based on ScreenRight1, yRight1, is not determined if the number of points in ScreenRight1 is insufficient. Also, yLeft1, an estimate of current measurement instance based on ScreenLeft1, is determined by performing a least-square error fit of a straight line using available points in ScreenLeft1, evaluated at the instance of the current measurement. The estimate of current measurement instance, yLeft1, is not determined if the number of points in ScreenLeft1 is insufficient.


If comparison within the second triplet can be performed, yCenter2, an estimate of current measurement instance based on ScreenCenter2, is determined by performing a least-square error fit of a straight line using available points in ScreenCenter2, evaluated at the instance of the current measurement. The estimate of current measurement instance based on ScreenCenter2, yCenter2 is not determined if the number of points in ScreenCenter2 is insufficient. Also, yRight2, an estimate of current measurement instance based on ScreenRight2, is determined by performing a least-square error fit of a straight line using available points in ScreenRight2, evaluated at the instance of the current measurement. The estimate of current measurement instance based on ScreenRight2, yRight2 is not determined if the number of points in ScreenRight2 is insufficient. Additionally, yLeft2, an estimate of current measurement instance based on ScreenLeft2, is determined by performing a least-square error fit of a straight line using available points in ScreenLeft2, evaluated at the instance of the current measurement. The estimate of current measurement instance based on ScreenLeft2, yLeft2 is not determined if the number of points in ScreenLeft2 is insufficient. Then, estimates of the current measurement instance based on the first triplet, yCenter1, yRight1, and yLeft1, are updated by estimates based on the second triplet (e.g. assign the value of yCenter2 to yCenter1, assign the value of yRight2 to yRight1, and assign yLeft2 to yLeft1), if the determination is available.


In addition, for each sampled data instance, if comparison within the first triplet can be performed, available yCenter1, yLeft1, and yRight1 measurements are collected, and the following values are determined: (1) yAvg, the average of the available values, (2) yMin, the smallest of the available values, (3) yMax, the largest of the available values, (4) yRange, the absolute value of the difference between yMin and yMax, and (5) yRelativeRange, the value of yRange divided by yAvg. Then, the values yRelativeRange and yRange are compared against the thresholds ScreenMaxRelativeRange and ScreenMaxRange, respectively. If either one exceeds the threshold, the current sampled glucose data instance is identified for removal. In certain embodiments, identifying for removal of any sampled glucose data instance is not performed until all sampled glucose data instances have been evaluated.


On the other hand, for each sampled glucose data instance, if the comparison within the first triplet cannot be performed (340), the sampled glucose data instance is not identified for removal. Thereafter, sampled glucose data instances identified for removal are removed from the data set under analysis (350).



FIG. 4 illustrates a flowchart for data conditioning and/or data recovery for smooth output of FIG. 2 in accordance with certain embodiments of the present disclosure. Referring to FIGS. 2 and 4, in certain embodiments, data conditioning and/or recovery performed to smooth the data output (220) (FIG. 2) includes identifying output instance relative to data sample (410). That is, instances where output is desired is defined by, for example, (1) defining output instances as instances where the original sampled glucose data are found in which case, the output instances will take on the same timestamps as the original data, (2) defining output instances as instances where the original sampled glucose data are found, but were not marked for removal at step 210 (FIG. 2), or (3) defining output instances by a new arbitrary, but regular, sample interval (e.g. once every 8 minutes, or once every 30 minutes).


Referring back to FIG. 4, after identifying output instance relative to data sample (410), multiple triplet of data time windows for identified output instance is defined (420). More particularly, in certain embodiments, for each identified output instance, more than one triplet of time windows are defined to process data streams with a range of data sample time intervals. Specifically, in certain embodiments, a first triplet of left, center, and right windows SmoothLeft1, SmoothCenter1, and SmoothRight1, respectively, are defined where (1) left window, SmoothLeft1 only looks at available measurements prior to the current instance (e.g. from 50 minutes ago to 5 minutes ago); (2) right window, SmoothRight1 only looks at available measurements after the current instance (e.g. from 5 minutes to 50 minutes after the current instance); and (3) center window, SmoothCenter1 only looks at available measurements before the current instance and after the current instance (e.g. within ±32 minutes of the current instance). In certain embodiments, each window requires a minimum number of available points (e.g. 2 for the center window, 3 for the left window, and 3 for the right window).


Furthermore, in certain embodiments, for each identified output instance, more than one triplet of time windows are defined to process data streams with a range of data sample time intervals by defining a second triplet of left, center, and right windows SmoothLeft2, SmoothCenter2, and SmoothRight2, where (1) left window is narrower than that of SmoothLeft1 (e.g. from 20 minutes ago to 5 minutes ago), but requires a larger number of minimum available points (e.g. 9 points); (2) right window is narrower than that of SmoothRight1 (e.g. from 5 minutes to 20 minutes after the current instance), but requires a larger number of minimum available points (e.g. 9 points), and (3) center window is narrower than that of SmoothCenter1 (e.g. from 7 minutes prior to 7 minutes after the current instance), but requires a larger number of minimum available points (e.g. 9 points).


Referring again to FIG. 4, after defining multiple triplet of data time windows for identified output instance (420), for each output instance, sampled glucose data that fall within the defined multiple triplets of time windows are identified (430). It is also determined whether the number of available sampled glucose data points in each time window meets the respective minimum number of points.


Thereafter, Least Square error fit analysis is performed to generate smoothed output data (440). For example, in certain embodiments, ySmoothCenter1, an estimate of current output instance based on SmoothCenter1, is determined by performing a least-square error fit of a straight line using available points in SmoothCenter1, evaluated at the current output instance. The estimate of current output instance based on SmoothCenter1, ySmoothCenter1 is not determined if the number of points in this window is insufficient. Also, ySmoothRight1, an estimate of current output instance based on SmoothRight1, is determined by performing a least-square error fit of a straight line using available points in SmoothRight1, evaluated at the current output instance. The estimate of current output instance based on SmoothRight1, ySmoothRight1 is not determined if the number of points in this window is insufficient. In addition, ySmoothLeft1, an estimate of current output instance based on SmoothLeft1, is determined by performing a least-square error fit of a straight line using available points in SmoothLeft1, evaluated at the current output instance. The estimate of current output instance based on SmoothLeft1, ySmoothLeft1 is not determined if the number of points in this window is insufficient. Moreover, ySmoothCenter2, an estimate of current output instance based on SmoothCenter2, is determined by performing a least-square error fit of a straight line using available points in SmoothCenter2, evaluated at the current output instance. Similarly, the estimate of current output instance based on SmoothCenter2, ySmoothCenter2 is not determined if the number of points in this window is insufficient. Otherwise, ySmoothCenter1 is updated by assigning the value of ySmoothCenter2 to ySmoothCenter1. Further, ySmoothRight2, an estimate of current output instance based on SmoothRight1, is determined by performing a least-square error fit of a straight line using available points in SmoothRight2, evaluated at the current output instance. Again, the estimate of current output instance based on SmoothRight1, ySmoothRight2 is not determined if the number of points in this window is insufficient. Otherwise, ySmoothRight1 is updated by assigning the value of ySmoothRight2 to ySmoothRight1. Still further, ySmoothLeft2, an estimate of current output instance based on SmoothLeft2, is determined by performing a least-square error fit of a straight line using available points in SmoothLeft2, evaluated at the current output instance. The estimate of current output instance based on SmoothLeft2, ySmoothLeft2 is not determined if the number of points in this window is insufficient. Otherwise, ySmoothLeft1 is updated by assigning the value of ySmoothLeft2 to ySmoothLeft1.


Thereafter, ySmoothAvgSide, the average of available ySmoothRight1 and ySmoothLeft1 is determined. If both ySmoothCenter1 and ySmoothAvgSide can be determined, ySmooth, the smoothed, final output for this output instance is determined, by assigning ySmooth as the average of ySmoothCenter1 and ySmoothAvgSide.


In the manner described above, in certain embodiments, the meal start and peak estimation routine includes performing sample data analysis to remove questionable data (210) and then performing data conditioning and/or data recovery for smooth output (220) to perform time series data conditioning (110) before the time derivatives for sample data in the time series data are determined (120).



FIG. 5 illustrates sample data analysis to remove questionable data and performing condition and/or data recovery for smooth output in conjunction with the routines above in certain embodiments of the present disclosure. As shown, sampled glucose data (x) are processed to screen out questionable data. After questionable data are removed, the dataset (circle) goes through the conditioning process described above to obtain the final output values (dots). In this example, the output instances are identical to the measurement instances.


In the manner described above, in certain embodiments of the present disclosure, meal start events and peak events are estimated or determined based on analysis of time series of sampled glucose data from, for example, an in vivo glucose sensor that generates signals corresponding to the monitored glucose level at a specific or programmed or programmable time intervals and which signals can be further processed and analyzed in the manner described above, to estimate meal start and peak events.


In certain embodiments, meal marker manually entered by the user is compared against the estimated meal start determined in accordance with the embodiments of the present disclosure based on sampled glucose data that includes real time data and historical data. A short elapsed time after the meal marker is entered, when the glucose measurements are sufficient to generate a nearby estimate, the user may be prompted (using an analyte monitoring device user interface, for example) to adjust the meal marker timestamp to the estimated instance. In this exemplary embodiment, no estimated meal start replaces user entered marker unless confirmed by the user.


In certain embodiments, retrospective and pseudo-retrospective analysis of time spaced sampled glucose data are performed to generate user viewable reports or analysis results associated with the meal start and peak meal response events estimation, and which are viewable on the user interface of a hand-held data communication device, a mobile telephone screen, a smart phone user interface, or computing device, where the analysis is performed based on collected glucose data acquired up to the current time.


In certain embodiments, data reports are generated based on the meal start event and/or peak meal response events estimated in accordance with the present disclosure, to replace, supplement, revise or confirm such reports that rely on either a) meal tags made by users, b) meal bolus indications from bolus calculators, insulin pumps or smart insulin injection systems, or c) fixed meal times.


In certain embodiments, the meal start event or peak meal response estimation routine in accordance with the present disclosure is used to either cross-check or confirm the absence of presence of meal tags manually entered by the user or a healthcare provider.


In certain embodiments, the meal start event or peak meal response estimation routine in accordance with the present disclosure is used in conjunction with a report or table that is generated from glucose data which is separated into 5 different time-of-day bins defined by fixed meal times and bedtime. The bins may be determined by meal start events based on the meal start event or peak meal response estimation routine in accordance with the present disclosure with predetermined categorization parameters, such as, for example, categorizing identified meal times as a particular meal. For instance, an estimated meal start event would be defined as breakfast if it occurred between 4 am and 10 am.


In certain embodiments, other report designs are contemplated. One example is a report that is used to determine fasting glucose level for diagnosing diabetes. The report algorithm in certain embodiments determine all of the breakfast start times and use a glucose value some time prior to these start values to generate a statistics such as fasting mean and standard deviation. These statistics are compared to thresholds to determine the degree of diabetes condition for the patient or the user. These statistics can also be used to adjust medication therapy—for instance, basal insulin or other medications that address fasting glucose levels.


Reconciling meal tags with the meal detection algorithm in accordance with the embodiments of the present disclosure can also be used to refine the default time of day windows to assist users that have different work and rest schedule, such as someone on a night shift. When the pattern changes (e.g. moves from one work shift to another), the report can be updated to adjust accordingly. However, the moving window-based insight on breakfast (as in the first meal since the longest fast of the day) and other meal times can remain properly grouped in spite of the change in what time of day the meals are ingested.


In certain embodiments, data report may be related to the glucose tolerance test. Typically, a glucose tolerance test is administered by measuring the glycemic response to a 75 gram CHO solution administered orally after fasting. This report would rather utilize a number of days of continuous data and determine the statistics that characterize the glycemic response to typical meals for the patient. Statistics may include mean peak glucose deviation and mean time of peak glucose. These statistics are generated based on data segments aligned by the estimated meal start times. These statistics can be compared to thresholds to determine the degree of diabetes condition for the patient. These statistics can also be used to adjust medication therapy—for instance, mean peak glucose deviation may be used to direct changes to meal-time insulin, and mean time of peak glucose could be used to adjust insulin response time settings or to adjust bolus timing.


In certain embodiments, the meal start event and peak meal response event estimation in accordance with the present disclosure provides meal times that can be used to confirm tagged meals and to identify missing tags when analyzing the data to determine a glycemic model from the data.


In certain embodiments, for closed loop control, the estimated meal start events or peak meal response (in real-time) can be used to prompt the user to indicate if they started eating without notifying the closed loop control system of the meal.


In certain embodiments, estimation of meal start events in accordance with the present disclosure is used to prompt the user to ask questions about the meal. One example is prompting the user for mealtime insulin and carbohydrate, if the meal detection suspects a meal has started, but no entry has been logged related to insulin or carbohydrate information. In certain embodiments, the estimated meal start event, after a pre-determined time delay (say 15 minutes), can be used to set up a reminder to dose insulin. In another embodiment, if an estimated meal start event is determined within the most recent hour (or two) of the current acquisition of the sampled glucose data, and if the retrospective analysis of past data warrants checking post-meal glucose (e.g. due to post-meal variability), a reminder can be set to prompt the user to verify the glucose level (for example, using a finger stick test) at a pre-determined duration since the last meal start.


In another embodiment, the user may be provided with a reviewable or selectable option on the user interface of the analyte monitoring device menu structure to try to recall meal starts. The user can scroll through the graph or listing of glucose values, overlaid with potential meal start instances estimated in accordance with the routines described above. In certain embodiments, any confirmed estimate may be stored or identified or marked as a meal event.


In yet another embodiment, the user entered meal markers and estimated start and peak pairs determined in accordance with the present disclosure may be reconciled in conjunction with a healthcare provider, when the data is retrospectively evaluated.


The various methods described herein for performing one or more processes also described herein may be embodied as computer programs (e.g., computer executable instructions and data structures) developed using an object oriented programming language that allows the modeling of complex systems with modular objects to create abstractions that are representative of real world, physical objects and their interrelationships. However, any practicable programming language and/or techniques may be used. The software for performing the inventive processes, which may be stored in a memory or storage device of the computer system described herein, may be developed by a person of ordinary skill in the art based upon the present disclosure and may include one or more computer program products. The computer program products may be stored on a computer readable medium such as a server memory, a computer network, the Internet, and/or a computer storage device. Note that in some cases the methods embodied as software may be described herein with respect to a particular order of operation or execution. However, it will be understood by one of ordinary skill that any practicable order of operation or execution is possible and such variations are contemplated by this specification of the present disclosure.


Various other modifications and alterations in the structure and method of operation of the embodiments of the present disclosure will be apparent to those skilled in the art without departing from the scope and spirit of the present disclosure. Although the present disclosure has been described in connection with certain embodiments, it should be understood that the present disclosure as claimed should not be unduly limited to such embodiments. It is intended that the following claims define the scope of the present disclosure and that structures and methods within the scope of these claims and their equivalents be covered thereby.


Certain embodiments of the present disclosure include performing conditioning on a plurality of data points corresponding to monitored analyte level over a first time period, for each data point, determining a time derivative based on the conditioned plurality of data points, determining optima of acceleration based on the determined time derivatives, removing false carbohydrate intake start and peak carbohydrate intake response pairs having an amplitude below a predetermined level, removing carbohydrate intake start candidate from the most current carbohydrate intake peak response candidate, removing unpaired carbohydrate intake start candidates and signal artifact falsely identified as carbohydrate intake start and carbohydrate intake peak response pair, and refining the identified carbohydrate intake start and peak carbohydrate intake response pairs.


In one aspect, performing conditioning on the plurality of data points corresponding to the monitored analyte level of the first time period includes performing sample data analysis on the plurality of data points to remove questionable data and smoothing the plurality of data points.


One aspect includes outputting an indication associated with a carbohydrate intake start event.


In a further aspect, the carbohydrate intake start event includes a meal start event.


Another aspect includes outputting an indication associated with a peak carbohydrate intake response event.


In a further aspect, the peak carbohydrate intake response event includes a peak meal response event.


Certain embodiments of the present disclosure include a user interface component and one or more processors operatively coupled to the user interface component, the one or more processors configured to perform conditioning on a plurality of data points corresponding to monitored analyte level over a first time period, for each data point, to determine a time derivative based on the conditioned plurality of data points, to determine optima of acceleration based on the determined time derivatives, to remove false carbohydrate intake start and peak carbohydrate intake response pairs having an amplitude below a predetermined level, to remove carbohydrate intake start candidate from the most current carbohydrate intake peak response candidate, to remove unpaired carbohydrate intake start candidates and signal artifact falsely identified as carbohydrate intake start and carbohydrate intake peak response pair, and to remove the identified carbohydrate intake start and peak carbohydrate intake response pairs.


In one aspect, the one or more processors configured to perform conditioning on the plurality of data points corresponding to the monitored analyte level of the first time period, is further configured to perform sample data analysis on the plurality of data points to remove questionable data, and to smooth the plurality of data points.


In another aspect, the one or more processors is configured to output an indication associated with a carbohydrate intake start event on the user interface component.


In one aspect, the carbohydrate intake start event includes a meal start event.


In another aspect, the one or more processors is configured to output an indication associated with a peak carbohydrate intake response event on the user interface component.


In another aspect, the peak carbohydrate intake response event includes a peak meal response event.

Claims
  • 1. A computer-implemented method of determining a second data set of carbohydrate intake start events and carbohydrate peak response events, the method comprising: determining time derivatives of a plurality of data points corresponding to a monitored analyte level;creating a first data set comprising a plurality of carbohydrate intake start candidates and a plurality of carbohydrate intake peak response candidates based on the determined time derivatives;removing one or more false carbohydrate intake start candidates or false carbohydrate peak response candidates from the first data set to create the second data set of carbohydrate intake start events and carbohydrate peak response events; andoutputting a recommended adjustment to a medication therapy based on the second data set of carbohydrate intake events and carbohydrate peak response events.
  • 2. The method of claim 1, further comprising adjusting the medication therapy based on the second data set of carbohydrate intake start events and carbohydrate peak response events.
  • 3. The method of claim 2, wherein adjusting the medication therapy comprises adjusting a basal delivery rate of an insulin pump.
  • 4. The method of claim 2, wherein adjusting the medication therapy comprises adjusting a bolus dosage level, an insulin response time setting, or a bolus timing setting.
  • 5. The method of claim 1, wherein removing the one or more false carbohydrate intake start candidates or false carbohydrate peak response candidates from the first data set includes removing one or more adjacent candidates of a same type.
  • 6. The method of claim 1, wherein removing the one or more false carbohydrate intake start candidates or false carbohydrate peak response candidates from the first data set includes removing a carbohydrate intake start candidate having a proximity or a level drop relative to an adjacent carbohydrate peak response candidate that is below a predetermined threshold.
  • 7. The method of claim 1, wherein removing the one or more false carbohydrate intake start candidates or false carbohydrate peak response candidates from the first data set includes removing one or more unpaired carbohydrate intake start candidates.
  • 8. The method of claim 1, wherein removing the one or more false carbohydrate intake start candidates or false carbohydrate peak response candidates from the first data set includes removing one or more signal artifacts.
  • 9. The method of claim 1, further comprising removing outlier data from the plurality of data points corresponding to the monitored analyte level, and smoothing the plurality of data points.
  • 10. The method of claim 1, further comprising refining temporal positions of the second data set of carbohydrate intake start events and carbohydrate peak response events.
  • 11. An apparatus, comprising: a user interface component; andone or more processors operatively coupled to the user interface component and a non-transitory computer readable memory, wherein the non-transitory computer readable memory is configured to store computer readable instructions that, when executed by the one or more processors, cause the one or more processors to: determine time derivatives of a plurality of data points corresponding to a monitored analyte level;create a first data set comprising a plurality of carbohydrate intake start candidates and a plurality of carbohydrate intake peak response candidates based on the determined time derivatives;remove one or more false carbohydrate intake start candidates or false carbohydrate peak response candidates from the first data set to create a second data set of carbohydrate intake start events and carbohydrate peak response events; andoutput a recommended adjustment to a medication therapy based on the second data set of carbohydrate intake events and carbohydrate peak response events.
  • 12. The apparatus of claim 11, wherein the computer readable instructions, when executed by the one or more processors, further cause the one or more processors to adjust the medication therapy based on the second data set of carbohydrate intake start events and carbohydrate peak response events.
  • 13. The apparatus of claim 11, wherein the computer readable instructions, when executed by the one or more processors, further cause the one or more processors to adjust a basal delivery rate of an insulin pump.
  • 14. The apparatus of claim 11, wherein the computer readable instructions, when executed by the one or more processors, further cause the one or more processors to adjust a bolus dosage level, an insulin response time setting, or a bolus timing setting.
  • 15. The apparatus of claim 11, wherein the one or more false carbohydrate intake start candidates or false carbohydrate peak response candidates includes one or more adjacent candidates of a same type.
  • 16. The apparatus of claim 11, wherein the one or more false carbohydrate intake start candidates or false carbohydrate peak response candidates includes a carbohydrate intake start candidate having a proximity or a level drop relative to an adjacent carbohydrate peak response candidate that is below a predetermined threshold.
  • 17. The apparatus of claim 11, wherein the one or more false carbohydrate intake start candidates or false carbohydrate peak response candidates includes one or more unpaired carbohydrate intake start candidates.
  • 18. The apparatus of claim 11, wherein the one or more false carbohydrate intake start candidates or false carbohydrate peak response candidates includes one or more signal artifacts.
  • 19. The apparatus of claim 11, wherein the computer readable instructions, when executed by the one or more processors, further cause the one or more processors to remove outlier data from the plurality of data points corresponding to the monitored analyte level, and smooth the plurality of data points.
  • 20. The apparatus of claim 11, wherein the computer readable instructions, when executed by the one or more processors, further cause the one or more processors to refine temporal positions of the second data set of carbohydrate intake start events and carbohydrate peak response events.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a continuation of U.S. patent application Ser. No. 15/300,711, filed Sep. 29, 2016, which is a national stage patent application under 35 U.S.C. § 371 claims priority to PCT Application Serial No. PCT/US2015/23380, filed Mar. 30, 2015, which claims priority to and the benefit of U.S. Provisional Patent Application Ser. No. 61/972,381, filed Mar. 30, 2014, all of which are incorporated by reference herein in their entireties for all purposes.

US Referenced Citations (1098)
Number Name Date Kind
3581062 Aston May 1971 A
3926760 Allen et al. Dec 1975 A
3949388 Fuller Apr 1976 A
3960497 Acord et al. Jun 1976 A
3978856 Michel Sep 1976 A
4036749 Anderson Jul 1977 A
4055175 Clemens et al. Oct 1977 A
4129128 McFarlane Dec 1978 A
4245634 Albisser et al. Jan 1981 A
4327725 Cortese et al. May 1982 A
4344438 Schultz Aug 1982 A
4349728 Phillips et al. Sep 1982 A
4373527 Fischell Feb 1983 A
4392849 Petre et al. Jul 1983 A
4425920 Bourland et al. Jan 1984 A
4441968 Emmer et al. Apr 1984 A
4462048 Ross Jul 1984 A
4478976 Goertz et al. Oct 1984 A
4494950 Fischell Jan 1985 A
4509531 Ward Apr 1985 A
4527240 Kvitash Jul 1985 A
4538616 Rogoff Sep 1985 A
4545382 Higgins et al. Oct 1985 A
4619793 Lee Oct 1986 A
4671288 Gough Jun 1987 A
4703756 Gough et al. Nov 1987 A
4711245 Higgins et al. Dec 1987 A
4731051 Fischell Mar 1988 A
4731726 Allen, III Mar 1988 A
4749985 Corsberg Jun 1988 A
4757022 Shults et al. Jul 1988 A
4759366 Callaghan Jul 1988 A
4777953 Ash et al. Oct 1988 A
4779618 Mund et al. Oct 1988 A
4854322 Ash et al. Aug 1989 A
4871351 Feingold Oct 1989 A
4890620 Gough Jan 1990 A
4925268 Iyer et al. May 1990 A
4947845 Davis Aug 1990 A
4953552 DeMarzo Sep 1990 A
4986271 Wilkins Jan 1991 A
4995402 Smith et al. Feb 1991 A
5000180 Kuypers et al. Mar 1991 A
5002054 Ash et al. Mar 1991 A
5019974 Beckers May 1991 A
5050612 Matsumura Sep 1991 A
5055171 Peck Oct 1991 A
5068536 Rosenthal Nov 1991 A
5077476 Rosenthal Dec 1991 A
5082550 Rishpon et al. Jan 1992 A
5106365 Hernandez Apr 1992 A
5113869 Nappholz et al. May 1992 A
5122925 Inpyn Jun 1992 A
5135004 Adams et al. Aug 1992 A
5148812 Verrier et al. Sep 1992 A
5165407 Wilson et al. Nov 1992 A
5199428 Obel et al. Apr 1993 A
5202261 Musho et al. Apr 1993 A
5203326 Collins Apr 1993 A
5204264 Kaminer et al. Apr 1993 A
5210778 Massart May 1993 A
5231988 Wernicke et al. Aug 1993 A
5246867 Lakowicz et al. Sep 1993 A
5262035 Gregg et al. Nov 1993 A
5262305 Heller et al. Nov 1993 A
5264104 Gregg et al. Nov 1993 A
5264105 Gregg et al. Nov 1993 A
5279294 Anderson et al. Jan 1994 A
5285792 Sjoquist et al. Feb 1994 A
5293877 O'Hara et al. Mar 1994 A
5299571 Mastrototaro Apr 1994 A
5313953 Yomtov et al. May 1994 A
5320715 Berg Jun 1994 A
5320725 Gregg et al. Jun 1994 A
5322063 Allen et al. Jun 1994 A
5328460 Lord et al. Jul 1994 A
5330634 Wong et al. Jul 1994 A
5340722 Wolfbeis et al. Aug 1994 A
5342789 Chick et al. Aug 1994 A
5356786 Heller et al. Oct 1994 A
5360404 Novacek et al. Nov 1994 A
5365426 Siegel et al. Nov 1994 A
5372427 Padovani et al. Dec 1994 A
5376070 Purvis et al. Dec 1994 A
5379238 Stark Jan 1995 A
5384547 Lynk et al. Jan 1995 A
5390671 Lord et al. Feb 1995 A
5391250 Cheney, II et al. Feb 1995 A
5400795 Murphy et al. Mar 1995 A
5408999 Singh et al. Apr 1995 A
5411647 Johnson et al. May 1995 A
5425749 Adams Jun 1995 A
5425868 Pedersen Jun 1995 A
5431160 Wilkins Jul 1995 A
5431921 Thombre Jul 1995 A
5438983 Falcone Aug 1995 A
5462645 Albery et al. Oct 1995 A
5472317 Field et al. Dec 1995 A
5489414 Schreiber et al. Feb 1996 A
5497772 Schulman et al. Mar 1996 A
5505828 Wong et al. Apr 1996 A
5507288 Bocker et al. Apr 1996 A
5509410 Hill et al. Apr 1996 A
5514718 Lewis et al. May 1996 A
5520191 Karlsson et al. May 1996 A
5531878 Vadgama et al. Jul 1996 A
5532686 Urbas et al. Jul 1996 A
5543326 Heller et al. Aug 1996 A
5552997 Massart Sep 1996 A
5568400 Stark et al. Oct 1996 A
5568806 Cheney, II et al. Oct 1996 A
5569186 Lord et al. Oct 1996 A
5582184 Erickson et al. Dec 1996 A
5586553 Halili et al. Dec 1996 A
5593852 Heller et al. Jan 1997 A
5601435 Quy Feb 1997 A
5609575 Larson et al. Mar 1997 A
5628310 Rao et al. May 1997 A
5628890 Carter et al. May 1997 A
5634468 Platt et al. Jun 1997 A
5640954 Pfeiffer et al. Jun 1997 A
5653239 Pompei et al. Aug 1997 A
5660163 Schulman et al. Aug 1997 A
5665222 Heller et al. Sep 1997 A
5707502 McCaffrey et al. Jan 1998 A
5711001 Bussan et al. Jan 1998 A
5711861 Ward et al. Jan 1998 A
5720295 Greenhut et al. Feb 1998 A
5724030 Urbas et al. Mar 1998 A
5733259 Valcke et al. Mar 1998 A
5735285 Albert et al. Apr 1998 A
5741211 Renirie et al. Apr 1998 A
5749907 Mann May 1998 A
5772586 Heinonen et al. Jun 1998 A
5785660 van Lake et al. Jul 1998 A
5791344 Schulman et al. Aug 1998 A
5792065 Xue et al. Aug 1998 A
5804047 Karube et al. Sep 1998 A
5820551 Hill et al. Oct 1998 A
5822715 Worthington et al. Oct 1998 A
5891047 Lander et al. Apr 1999 A
5891049 Cyrus et al. Apr 1999 A
5899855 Brown May 1999 A
5914026 Blubaugh, Jr. et al. Jun 1999 A
5918603 Brown Jul 1999 A
5925021 Castellano et al. Jul 1999 A
5935224 Svancarek et al. Aug 1999 A
5942979 Luppino Aug 1999 A
5951485 Cyrus et al. Sep 1999 A
5957854 Besson et al. Sep 1999 A
5960797 Kramer et al. Oct 1999 A
5961451 Reber et al. Oct 1999 A
5964993 Blubaugh, Jr. et al. Oct 1999 A
5965380 Heller et al. Oct 1999 A
5971922 Arita et al. Oct 1999 A
5995860 Sun et al. Nov 1999 A
6001067 Shults et al. Dec 1999 A
6016443 Ekwall et al. Jan 2000 A
6021350 Mathson Feb 2000 A
6024699 Surwit et al. Feb 2000 A
6038469 Karlsson et al. Mar 2000 A
6049727 Crothall Apr 2000 A
6071391 Gotoh et al. Jun 2000 A
6073031 Helstab et al. Jun 2000 A
6083710 Heller et al. Jul 2000 A
6088608 Schulman et al. Jul 2000 A
6091976 Pfeiffer et al. Jul 2000 A
6091987 Thompson Jul 2000 A
6093172 Funderburk et al. Jul 2000 A
6103033 Say et al. Aug 2000 A
6108577 Benser Aug 2000 A
6112116 Fischell Aug 2000 A
6115622 Minoz Sep 2000 A
6115628 Stadler et al. Sep 2000 A
6117290 Say et al. Sep 2000 A
6119028 Schulman et al. Sep 2000 A
6120676 Heller et al. Sep 2000 A
6121009 Heller et al. Sep 2000 A
6121611 Lindsay et al. Sep 2000 A
6122351 Schlueter, Jr. et al. Sep 2000 A
6128526 Stadler et al. Oct 2000 A
6130623 MacLellan et al. Oct 2000 A
6134461 Say et al. Oct 2000 A
6143164 Heller et al. Nov 2000 A
6144837 Quy Nov 2000 A
6144871 Saito et al. Nov 2000 A
6159147 Lichter et al. Dec 2000 A
6161095 Brown Dec 2000 A
6162611 Heller et al. Dec 2000 A
6175752 Say et al. Jan 2001 B1
6200265 Walsh et al. Mar 2001 B1
6212416 Ward et al. Apr 2001 B1
6219574 Cormier et al. Apr 2001 B1
6223283 Chaiken et al. Apr 2001 B1
6233471 Berner et al. May 2001 B1
6233486 Ekwall et al. May 2001 B1
6248067 Causey, III et al. Jun 2001 B1
6249705 Snell Jun 2001 B1
6254586 Mann et al. Jul 2001 B1
6256538 Ekwall Jul 2001 B1
6264606 Ekwall et al. Jul 2001 B1
6270455 Brown Aug 2001 B1
6272379 Fischell et al. Aug 2001 B1
6275717 Gross et al. Aug 2001 B1
6283761 Joao Sep 2001 B1
6284478 Heller et al. Sep 2001 B1
6291200 LeJeune et al. Sep 2001 B1
6293925 Safabash et al. Sep 2001 B1
6294997 Paratore et al. Sep 2001 B1
6295506 Heinonen et al. Sep 2001 B1
6299757 Feldman et al. Oct 2001 B1
6306104 Cunningham et al. Oct 2001 B1
6309884 Cooper et al. Oct 2001 B1
6329161 Heller et al. Dec 2001 B1
6338790 Feldman et al. Jan 2002 B1
6348640 Navot et al. Feb 2002 B1
6359444 Grimes Mar 2002 B1
6360888 McIvor et al. Mar 2002 B1
6361503 Starobin et al. Mar 2002 B1
6366794 Moussy et al. Apr 2002 B1
6377828 Chaiken et al. Apr 2002 B1
6377852 Bornzin et al. Apr 2002 B1
6377894 Deweese et al. Apr 2002 B1
6379301 Worthington et al. Apr 2002 B1
6381493 Stadler et al. Apr 2002 B1
6387048 Schulman et al. May 2002 B1
6400974 Lesho Jun 2002 B1
6405066 Essenpreis et al. Jun 2002 B1
6413393 Van Antwerp et al. Jul 2002 B1
6416471 Kumar et al. Jul 2002 B1
6418346 Nelson et al. Jul 2002 B1
6424847 Mastrototaro et al. Jul 2002 B1
6427088 Bowman, IV et al. Jul 2002 B1
6440068 Brown et al. Aug 2002 B1
6461496 Feldman et al. Oct 2002 B1
6471689 Joseph et al. Oct 2002 B1
6478736 Mault Nov 2002 B1
6484046 Say et al. Nov 2002 B1
6496729 Thompson Dec 2002 B2
6497655 Linberg et al. Dec 2002 B1
6501983 Natarajan et al. Dec 2002 B1
6503381 Gotoh et al. Jan 2003 B1
6514460 Fendrock Feb 2003 B1
6514718 Heller et al. Feb 2003 B2
6520326 McIvor et al. Feb 2003 B2
6540891 Stewart et al. Apr 2003 B1
6544212 Galley et al. Apr 2003 B2
6549796 Sohrab Apr 2003 B2
6551494 Heller et al. Apr 2003 B1
6558320 Causey, III et al. May 2003 B1
6558321 Burd et al. May 2003 B1
6558351 Steil et al. May 2003 B1
6560471 Heller et al. May 2003 B1
6561975 Pool et al. May 2003 B1
6561978 Conn et al. May 2003 B1
6562001 Lebel et al. May 2003 B2
6564105 Starkweather et al. May 2003 B2
6565509 Say et al. May 2003 B1
6571128 Lebel et al. May 2003 B2
6572542 Houben et al. Jun 2003 B1
6574490 Abbink et al. Jun 2003 B2
6574510 Von Arx et al. Jun 2003 B2
6576101 Heller et al. Jun 2003 B1
6577899 Lebel et al. Jun 2003 B2
6579231 Phipps Jun 2003 B1
6579690 Bonnecaze et al. Jun 2003 B1
6585644 Lebel et al. Jul 2003 B2
6591125 Buse et al. Jul 2003 B1
6592745 Feldman et al. Jul 2003 B1
6595919 Berner et al. Jul 2003 B2
6600997 Deweese et al. Jul 2003 B2
6605200 Mao et al. Aug 2003 B1
6605201 Mao et al. Aug 2003 B1
6607509 Bobroff et al. Aug 2003 B2
6610012 Mault Aug 2003 B2
6616819 Liamos et al. Sep 2003 B1
6618934 Feldman et al. Sep 2003 B1
6622045 Snell et al. Sep 2003 B2
6633772 Ford et al. Oct 2003 B2
6635014 Starkweather et al. Oct 2003 B2
6635167 Batman et al. Oct 2003 B1
6641533 Causey, III et al. Nov 2003 B2
6648821 Lebel et al. Nov 2003 B2
6650471 Doi Nov 2003 B2
6654625 Say et al. Nov 2003 B1
6656114 Poulson et al. Dec 2003 B1
6658396 Tang et al. Dec 2003 B1
6659948 Lebel et al. Dec 2003 B2
6668196 Villegas et al. Dec 2003 B1
6675030 Ciuczak et al. Jan 2004 B2
6676816 Mao et al. Jan 2004 B2
6687546 Lebel et al. Feb 2004 B2
6689056 Kilcoyne et al. Feb 2004 B1
6694191 Starkweather et al. Feb 2004 B2
6695860 Ward et al. Feb 2004 B1
6698269 Baber et al. Mar 2004 B2
6702857 Brauker et al. Mar 2004 B2
6721582 Trepagnier et al. Apr 2004 B2
6730200 Stewart et al. May 2004 B1
6731976 Penn et al. May 2004 B2
6731985 Poore et al. May 2004 B2
6733446 Lebel et al. May 2004 B2
6735183 O'Toole et al. May 2004 B2
6736957 Forrow et al. May 2004 B1
6740075 Lebel et al. May 2004 B2
6741877 Shults et al. May 2004 B1
6746582 Heller et al. Jun 2004 B2
6749740 Liamos et al. Jun 2004 B2
6758810 Lebel et al. Jul 2004 B2
6764581 Forrow et al. Jul 2004 B1
6770030 Schaupp et al. Aug 2004 B1
6773671 Lewis et al. Aug 2004 B1
6790178 Mault et al. Sep 2004 B1
6804558 Haller et al. Oct 2004 B2
6809653 Mann et al. Oct 2004 B1
6810290 Lebel et al. Oct 2004 B2
6811533 Lebel et al. Nov 2004 B2
6811534 Bowman, IV et al. Nov 2004 B2
6813519 Lebel et al. Nov 2004 B2
6850790 Berner et al. Feb 2005 B2
6862465 Shults et al. Mar 2005 B2
6865407 Kimball et al. Mar 2005 B2
6873268 Lebel et al. Mar 2005 B2
6878112 Linberg et al. Apr 2005 B2
6881551 Heller et al. Apr 2005 B2
6882940 Potts et al. Apr 2005 B2
6892085 McIvor et al. May 2005 B2
6893545 Gotoh et al. May 2005 B2
6895263 Shin et al. May 2005 B2
6895265 Silver May 2005 B2
6912413 Rantala et al. Jun 2005 B2
6923763 Kovatchev et al. Aug 2005 B1
6923764 Aceti et al. Aug 2005 B2
6931327 Goode, Jr. et al. Aug 2005 B2
6932892 Chen et al. Aug 2005 B2
6932894 Mao et al. Aug 2005 B2
6936006 Sabra Aug 2005 B2
6940403 Kail, IV Sep 2005 B2
6941163 Ford et al. Sep 2005 B2
6942518 Liamos et al. Sep 2005 B2
6950708 Bowman, IV et al. Sep 2005 B2
6954662 Freger et al. Oct 2005 B2
6958705 Lebel et al. Oct 2005 B2
6968294 Gutta et al. Nov 2005 B2
6971274 Olin Dec 2005 B2
6974437 Lebel et al. Dec 2005 B2
6990366 Say et al. Jan 2006 B2
6997907 Safabash et al. Feb 2006 B2
6998247 Monfre et al. Feb 2006 B2
7003336 Holker et al. Feb 2006 B2
7003340 Say et al. Feb 2006 B2
7003341 Say et al. Feb 2006 B2
7009511 Mazar et al. Mar 2006 B2
7010345 Hill et al. Mar 2006 B2
7011630 Desai et al. Mar 2006 B2
7016713 Gardner et al. Mar 2006 B2
7016720 Kroll Mar 2006 B2
7020508 Stivoric et al. Mar 2006 B2
7022072 Fox et al. Apr 2006 B2
7022219 Mansouri et al. Apr 2006 B2
7024236 Ford et al. Apr 2006 B2
7024245 Lebel et al. Apr 2006 B2
7025425 Kovatchev et al. Apr 2006 B2
7029443 Kroll Apr 2006 B2
7029444 Shin et al. Apr 2006 B2
7041068 Freeman et al. May 2006 B2
7041468 Drucker et al. May 2006 B2
7043287 Khalil et al. May 2006 B1
7043305 KenKnight et al. May 2006 B2
7052472 Miller et al. May 2006 B1
7052483 Wojcik May 2006 B2
7056302 Douglas Jun 2006 B2
7058453 Nelson et al. Jun 2006 B2
7060031 Webb et al. Jun 2006 B2
7074307 Simpson et al. Jul 2006 B2
7076300 Kroll et al. Jul 2006 B1
7081195 Simpson et al. Jul 2006 B2
7082334 Boute et al. Jul 2006 B2
7092891 Maus et al. Aug 2006 B2
7096064 Deno et al. Aug 2006 B2
7098803 Mann et al. Aug 2006 B2
7103412 Kroll Sep 2006 B1
7108778 Simpson et al. Sep 2006 B2
7110803 Shults et al. Sep 2006 B2
7113821 Sun et al. Sep 2006 B1
7118667 Lee Oct 2006 B2
7123950 Mannheimer Oct 2006 B2
7125382 Zhou et al. Oct 2006 B2
7134999 Brauker et al. Nov 2006 B2
7136689 Shults et al. Nov 2006 B2
7142911 Boileau et al. Nov 2006 B2
7153265 Vachon Dec 2006 B2
7167818 Brown Jan 2007 B2
7171274 Starkweather et al. Jan 2007 B2
7183102 Monfre et al. Feb 2007 B2
7190988 Say et al. Mar 2007 B2
7192450 Brauker et al. Mar 2007 B2
7198606 Boecker et al. Apr 2007 B2
7203549 Schommer et al. Apr 2007 B2
7225535 Feldman et al. Jun 2007 B2
7226978 Tapsak et al. Jun 2007 B2
7228182 Healy et al. Jun 2007 B2
7237712 DeRocco et al. Jul 2007 B2
7258673 Racchini et al. Aug 2007 B2
7267665 Steil et al. Sep 2007 B2
7272436 Gill et al. Sep 2007 B2
7276029 Goode, Jr. et al. Oct 2007 B2
7278983 Ireland et al. Oct 2007 B2
7295867 Berner et al. Nov 2007 B2
7297114 Gill et al. Nov 2007 B2
7299082 Feldman et al. Nov 2007 B2
7310544 Brister et al. Dec 2007 B2
7317938 Lorenz et al. Jan 2008 B2
7318816 Bobroff et al. Jan 2008 B2
7324850 Persen et al. Jan 2008 B2
7335294 Heller et al. Feb 2008 B2
7347819 Lebel et al. Mar 2008 B2
7354420 Steil et al. Apr 2008 B2
7364592 Carr-Brendel et al. Apr 2008 B2
7366556 Brister et al. Apr 2008 B2
7379765 Petisce et al. May 2008 B2
7384397 Zhang et al. Jun 2008 B2
7387010 Sunshine et al. Jun 2008 B2
7399277 Saidara et al. Jul 2008 B2
7402153 Steil et al. Jul 2008 B2
7404796 Ginsberg Jul 2008 B2
7419573 Gundel Sep 2008 B2
7424318 Brister et al. Sep 2008 B2
7460898 Brister et al. Dec 2008 B2
7467003 Brister et al. Dec 2008 B2
7468125 Kraft et al. Dec 2008 B2
7471972 Rhodes et al. Dec 2008 B2
7474992 Ariyur Jan 2009 B2
7492254 Bandy et al. Feb 2009 B2
7494465 Brister et al. Feb 2009 B2
7497827 Brister et al. Mar 2009 B2
7499002 Blasko et al. Mar 2009 B2
7502644 Gill et al. Mar 2009 B2
7519408 Rasdal et al. Apr 2009 B2
7519478 Bartkowiak et al. Apr 2009 B2
7523004 Bartkowiak et al. Apr 2009 B2
7524287 Bharmi Apr 2009 B2
7547281 Hayes et al. Jun 2009 B2
7565197 Haubrich et al. Jul 2009 B2
7569030 Lebel et al. Aug 2009 B2
7574266 Dudding et al. Aug 2009 B2
7583990 Goode, Jr. et al. Sep 2009 B2
7591801 Brauker et al. Sep 2009 B2
7599726 Goode, Jr. et al. Oct 2009 B2
7602310 Mann et al. Oct 2009 B2
7604178 Stewart Oct 2009 B2
7613491 Boock et al. Nov 2009 B2
7615007 Shults et al. Nov 2009 B2
7618369 Hayter et al. Nov 2009 B2
7630748 Budiman Dec 2009 B2
7632228 Brauker et al. Dec 2009 B2
7635594 Holmes et al. Dec 2009 B2
7637868 Saint et al. Dec 2009 B2
7640048 Dobbles et al. Dec 2009 B2
7659823 Killian et al. Feb 2010 B1
7668596 Von Arx et al. Feb 2010 B2
7699775 Desai et al. Apr 2010 B2
7699964 Feldman et al. Apr 2010 B2
7711493 Bartkowiak et al. May 2010 B2
7736310 Taub et al. Jun 2010 B2
7741734 Joannopoulos et al. Jun 2010 B2
7751864 Buck, Jr. Jul 2010 B2
7766829 Sloan et al. Aug 2010 B2
7771352 Shults et al. Aug 2010 B2
7774145 Bruaker et al. Aug 2010 B2
7778680 Goode, Jr. et al. Aug 2010 B2
7779332 Karr et al. Aug 2010 B2
7782192 Jeckelmann et al. Aug 2010 B2
7783333 Brister et al. Aug 2010 B2
7791467 Mazar et al. Sep 2010 B2
7792562 Shults et al. Sep 2010 B2
7826981 Goode, Jr. et al. Nov 2010 B2
7831310 Lebel et al. Nov 2010 B2
7857760 Brister et al. Dec 2010 B2
7860574 Von Arx et al. Dec 2010 B2
7866026 Wang et al. Jan 2011 B1
7882611 Shah et al. Feb 2011 B2
7885697 Brister et al. Feb 2011 B2
7889069 Fifolt et al. Feb 2011 B2
7899511 Shults et al. Mar 2011 B2
7905833 Brister et al. Mar 2011 B2
7912674 Killoren Clark et al. Mar 2011 B2
7914450 Goode, Jr. et al. Mar 2011 B2
7916013 Stevenson Mar 2011 B2
7938797 Estes May 2011 B2
7946984 Brister et al. May 2011 B2
7955258 Goscha et al. Jun 2011 B2
7970448 Shults et al. Jun 2011 B2
7974672 Shults et al. Jul 2011 B2
7999674 Kamen Aug 2011 B2
8060173 Goode, Jr. et al. Nov 2011 B2
8072310 Everhart Dec 2011 B1
8090445 Ginggen Jan 2012 B2
8093991 Stevenson et al. Jan 2012 B2
8094009 Allen et al. Jan 2012 B2
8098159 Batra et al. Jan 2012 B2
8098160 Howarth et al. Jan 2012 B2
8098161 Lavedas Jan 2012 B2
8098201 Choi et al. Jan 2012 B2
8098208 Ficker et al. Jan 2012 B2
8102021 Degani Jan 2012 B2
8102154 Bishop et al. Jan 2012 B2
8102263 Yeo et al. Jan 2012 B2
8102789 Rosar et al. Jan 2012 B2
8103241 Young et al. Jan 2012 B2
8103325 Swedlow et al. Jan 2012 B2
8111042 Bennett Feb 2012 B2
8115488 McDowell Feb 2012 B2
8116681 Baarman Feb 2012 B2
8116683 Baarman Feb 2012 B2
8116837 Huang Feb 2012 B2
8117481 Anselmi et al. Feb 2012 B2
8120493 Burr Feb 2012 B2
8124452 Sheats Feb 2012 B2
8130093 Mazar et al. Mar 2012 B2
8131351 Kalgren et al. Mar 2012 B2
8131365 Zhang et al. Mar 2012 B2
8131565 Dicks et al. Mar 2012 B2
8132037 Fehr et al. Mar 2012 B2
8135352 Langsweirdt et al. Mar 2012 B2
8136735 Arai et al. Mar 2012 B2
8138925 Downie et al. Mar 2012 B2
8140160 Pless et al. Mar 2012 B2
8140168 Olson et al. Mar 2012 B2
8140299 Siess Mar 2012 B2
8140312 Hayter et al. Mar 2012 B2
8150321 Winter et al. Apr 2012 B2
8150516 Levine et al. Apr 2012 B2
8160900 Taub et al. Apr 2012 B2
8170803 Kamath et al. May 2012 B2
8179266 Hermle May 2012 B2
8216138 McGarraugh et al. Jul 2012 B1
8224415 Budiman et al. Jul 2012 B2
8231531 Brister et al. Jul 2012 B2
8239166 Hayter et al. Aug 2012 B2
8255026 Al-Ali Aug 2012 B1
8282549 Brauker et al. Oct 2012 B2
8376945 Hayter et al. Feb 2013 B2
8444560 Hayter et al. May 2013 B2
8457703 Al-Ali Jun 2013 B2
8484005 Hayter et al. Jul 2013 B2
8532935 Budiman Sep 2013 B2
8543354 Luo et al. Sep 2013 B2
8571808 Hayter Oct 2013 B2
8612163 Hayter et al. Dec 2013 B2
8657746 Roy Feb 2014 B2
8682615 Hayter et al. Mar 2014 B2
9060719 Hayter et al. Jun 2015 B2
9398872 Hayter et al. Jul 2016 B2
9408566 Hayter et al. Aug 2016 B2
9483608 Hayter et al. Nov 2016 B2
9558325 Hayter et al. Jan 2017 B2
20010041831 Starkweather et al. Nov 2001 A1
20020016534 Trepagnier et al. Feb 2002 A1
20020019022 Dunn et al. Feb 2002 A1
20020042090 Heller et al. Apr 2002 A1
20020065454 Lebel et al. May 2002 A1
20020068860 Clark Jun 2002 A1
20020072784 Sheppard et al. Jun 2002 A1
20020103499 Perez et al. Aug 2002 A1
20020106709 Potts et al. Aug 2002 A1
20020120186 Keimel Aug 2002 A1
20020128594 Das et al. Sep 2002 A1
20020143266 Bock Oct 2002 A1
20020143372 Snell et al. Oct 2002 A1
20020161288 Shin et al. Oct 2002 A1
20020169635 Shillingburg Nov 2002 A1
20020193679 Malave et al. Dec 2002 A1
20030004403 Drinan et al. Jan 2003 A1
20030023317 Brauker et al. Jan 2003 A1
20030023461 Quintanilla et al. Jan 2003 A1
20030032867 Crothall et al. Feb 2003 A1
20030032874 Rhodes et al. Feb 2003 A1
20030042137 Mao et al. Mar 2003 A1
20030050546 Desai et al. Mar 2003 A1
20030054428 Monfre et al. Mar 2003 A1
20030065308 Lebel et al. Apr 2003 A1
20030088166 Say et al. May 2003 A1
20030100821 Heller et al. May 2003 A1
20030125612 Fox et al. Jul 2003 A1
20030130616 Steil et al. Jul 2003 A1
20030134347 Heller et al. Jul 2003 A1
20030168338 Gao et al. Sep 2003 A1
20030176933 Lebel et al. Sep 2003 A1
20030187338 Say et al. Oct 2003 A1
20030191377 Robinson et al. Oct 2003 A1
20030199744 Buse et al. Oct 2003 A1
20030199790 Boecker et al. Oct 2003 A1
20030208113 Mault et al. Nov 2003 A1
20030212317 Kovatchev et al. Nov 2003 A1
20030212379 Bylund et al. Nov 2003 A1
20030216630 Jersey-Willuhn et al. Nov 2003 A1
20030217966 Tapsak et al. Nov 2003 A1
20030235817 Bartkowiak et al. Dec 2003 A1
20040010186 Kimball et al. Jan 2004 A1
20040010207 Flaherty et al. Jan 2004 A1
20040011671 Shults et al. Jan 2004 A1
20040024553 Monfre et al. Feb 2004 A1
20040039298 Abreu Feb 2004 A1
20040040840 Mao et al. Mar 2004 A1
20040045879 Shults et al. Mar 2004 A1
20040054263 Moerman et al. Mar 2004 A1
20040064068 DeNuzzio et al. Apr 2004 A1
20040077962 Kroll Apr 2004 A1
20040078065 Kroll Apr 2004 A1
20040093167 Braig et al. May 2004 A1
20040099529 Mao et al. May 2004 A1
20040106858 Say et al. Jun 2004 A1
20040122353 Shahmirian et al. Jun 2004 A1
20040133164 Funderburk et al. Jul 2004 A1
20040135684 Steinthal et al. Jul 2004 A1
20040138588 Saikley et al. Jul 2004 A1
20040138716 Kon et al. Jul 2004 A1
20040142403 Hetzel et al. Jul 2004 A1
20040146909 Duong et al. Jul 2004 A1
20040152622 Keith et al. Aug 2004 A1
20040162678 Hetzel et al. Aug 2004 A1
20040167801 Say et al. Aug 2004 A1
20040171921 Say et al. Sep 2004 A1
20040172307 Gruber Sep 2004 A1
20040176672 Silver et al. Sep 2004 A1
20040186362 Brauker et al. Sep 2004 A1
20040186365 Jin et al. Sep 2004 A1
20040193025 Steil et al. Sep 2004 A1
20040193090 Lebel et al. Sep 2004 A1
20040197846 Hockersmith et al. Oct 2004 A1
20040199056 Husemann et al. Oct 2004 A1
20040199059 Brauker et al. Oct 2004 A1
20040204687 Mogensen et al. Oct 2004 A1
20040208780 Faries, Jr. et al. Oct 2004 A1
20040225338 Lebel et al. Nov 2004 A1
20040236200 Say et al. Nov 2004 A1
20040249253 Racchini et al. Dec 2004 A1
20040249420 Olson et al. Dec 2004 A1
20040254433 Bandis et al. Dec 2004 A1
20040254434 Goodnow et al. Dec 2004 A1
20040260478 Schwamm Dec 2004 A1
20040263354 Mann et al. Dec 2004 A1
20040267300 Mace Dec 2004 A1
20050003470 Nelson et al. Jan 2005 A1
20050004439 Shin et al. Jan 2005 A1
20050004494 Perez et al. Jan 2005 A1
20050010087 Banet et al. Jan 2005 A1
20050010269 Lebel et al. Jan 2005 A1
20050016276 Guan et al. Jan 2005 A1
20050017864 Tsoukalis Jan 2005 A1
20050027177 Shin et al. Feb 2005 A1
20050027180 Goode et al. Feb 2005 A1
20050027181 Goode et al. Feb 2005 A1
20050027462 Goode et al. Feb 2005 A1
20050027463 Goode et al. Feb 2005 A1
20050031689 Shults et al. Feb 2005 A1
20050038332 Saidara et al. Feb 2005 A1
20050043598 Goode, Jr. et al. Feb 2005 A1
20050049179 Davidson et al. Mar 2005 A1
20050049473 Desai et al. Mar 2005 A1
20050070774 Addison et al. Mar 2005 A1
20050090607 Tapsak et al. Apr 2005 A1
20050096511 Fox et al. May 2005 A1
20050096512 Fox et al. May 2005 A1
20050112169 Brauker et al. May 2005 A1
20050113653 Fox et al. May 2005 A1
20050114068 Chey et al. May 2005 A1
20050115832 Simpson et al. Jun 2005 A1
20050121322 Say et al. Jun 2005 A1
20050131346 Douglas Jun 2005 A1
20050143635 Kamath et al. Jun 2005 A1
20050154271 Rasdal et al. Jul 2005 A1
20050176136 Burd et al. Aug 2005 A1
20050177398 Watanabe et al. Aug 2005 A1
20050182306 Sloan Aug 2005 A1
20050187720 Goode, Jr. et al. Aug 2005 A1
20050192494 Ginsberg Sep 2005 A1
20050192557 Brauker et al. Sep 2005 A1
20050195930 Spital et al. Sep 2005 A1
20050196821 Monfre et al. Sep 2005 A1
20050199494 Say et al. Sep 2005 A1
20050203360 Brauker et al. Sep 2005 A1
20050214892 Kovatchev et al. Sep 2005 A1
20050239154 Feldman et al. Oct 2005 A1
20050239156 Drucker et al. Oct 2005 A1
20050241957 Mao et al. Nov 2005 A1
20050245795 Goode, Jr. et al. Nov 2005 A1
20050245799 Brauker et al. Nov 2005 A1
20050245839 Stivoric et al. Nov 2005 A1
20050245904 Estes et al. Nov 2005 A1
20050277164 Drucker et al. Dec 2005 A1
20050277912 John Dec 2005 A1
20050287620 Heller et al. Dec 2005 A1
20050288725 Hettrick et al. Dec 2005 A1
20060001538 Kraft et al. Jan 2006 A1
20060004270 Bedard et al. Jan 2006 A1
20060010098 Goodnow et al. Jan 2006 A1
20060015020 Neale et al. Jan 2006 A1
20060015024 Brister et al. Jan 2006 A1
20060016700 Brister et al. Jan 2006 A1
20060017923 Ruchti et al. Jan 2006 A1
20060019327 Brister et al. Jan 2006 A1
20060020186 Brister et al. Jan 2006 A1
20060020187 Brister et al. Jan 2006 A1
20060020188 Kamath et al. Jan 2006 A1
20060020189 Brister et al. Jan 2006 A1
20060020190 Kamath et al. Jan 2006 A1
20060020191 Brister et al. Jan 2006 A1
20060020192 Brister et al. Jan 2006 A1
20060025662 Buse et al. Feb 2006 A1
20060025663 Talbot et al. Feb 2006 A1
20060029177 Cranford, Jr. et al. Feb 2006 A1
20060031094 Cohen et al. Feb 2006 A1
20060036139 Brister et al. Feb 2006 A1
20060036140 Brister et al. Feb 2006 A1
20060036141 Kamath et al. Feb 2006 A1
20060036142 Brister et al. Feb 2006 A1
20060036143 Brister et al. Feb 2006 A1
20060036144 Brister et al. Feb 2006 A1
20060036145 Brister et al. Feb 2006 A1
20060058588 Zdeblick Mar 2006 A1
20060091006 Wang et al. May 2006 A1
20060142651 Brister et al. Jun 2006 A1
20060155180 Brister et al. Jul 2006 A1
20060166629 Reggiardo Jul 2006 A1
20060167365 Bharmi Jul 2006 A1
20060167517 Gill et al. Jul 2006 A1
20060167518 Gill et al. Jul 2006 A1
20060167519 Gill et al. Jul 2006 A1
20060173260 Gaoni et al. Aug 2006 A1
20060173406 Hayes et al. Aug 2006 A1
20060173444 Choy et al. Aug 2006 A1
20060183984 Dobbles et al. Aug 2006 A1
20060183985 Brister et al. Aug 2006 A1
20060189851 Tvig et al. Aug 2006 A1
20060189863 Peyser et al. Aug 2006 A1
20060193375 Lee Aug 2006 A1
20060222566 Brauker et al. Oct 2006 A1
20060224109 Steil et al. Oct 2006 A1
20060226985 Goodnow et al. Oct 2006 A1
20060229512 Petisce et al. Oct 2006 A1
20060247508 Fennell Nov 2006 A1
20060247685 Bharmi Nov 2006 A1
20060247710 Goetz et al. Nov 2006 A1
20060247985 Liamos et al. Nov 2006 A1
20060258929 Goode et al. Nov 2006 A1
20060264785 Dring et al. Nov 2006 A1
20060272652 Stocker et al. Dec 2006 A1
20060281985 Ward et al. Dec 2006 A1
20060287691 Drew Dec 2006 A1
20070016381 Kamath et al. Jan 2007 A1
20070027381 Stafford Feb 2007 A1
20070032706 Kamath et al. Feb 2007 A1
20070033074 Nitzan et al. Feb 2007 A1
20070038044 Dobbles et al. Feb 2007 A1
20070055799 Koehler et al. Mar 2007 A1
20070056858 Chen et al. Mar 2007 A1
20070060803 Liljeryd et al. Mar 2007 A1
20070060814 Stafford Mar 2007 A1
20070066873 Kamath et al. Mar 2007 A1
20070068807 Feldman et al. Mar 2007 A1
20070071681 Gadkar et al. Mar 2007 A1
20070073129 Shah et al. Mar 2007 A1
20070078320 Stafford Apr 2007 A1
20070078321 Mazza et al. Apr 2007 A1
20070078322 Stafford Apr 2007 A1
20070078323 Reggiardo et al. Apr 2007 A1
20070095661 Wang et al. May 2007 A1
20070106135 Sloan et al. May 2007 A1
20070108048 Wang et al. May 2007 A1
20070118405 Campbell et al. May 2007 A1
20070124002 Estes et al. May 2007 A1
20070129621 Kellogg et al. Jun 2007 A1
20070149875 Ouyang et al. Jun 2007 A1
20070156033 Causey, III et al. Jul 2007 A1
20070163880 Woo et al. Jul 2007 A1
20070168224 Letzt et al. Jul 2007 A1
20070173706 Neinast et al. Jul 2007 A1
20070173709 Petisce et al. Jul 2007 A1
20070173710 Petisce et al. Jul 2007 A1
20070173761 Kanderian et al. Jul 2007 A1
20070179349 Hoyme et al. Aug 2007 A1
20070179352 Randlov et al. Aug 2007 A1
20070179434 Weinert et al. Aug 2007 A1
20070191701 Feldman et al. Aug 2007 A1
20070199818 Petyt et al. Aug 2007 A1
20070202562 Curry et al. Aug 2007 A1
20070203407 Hoss et al. Aug 2007 A1
20070203966 Brauker et al. Aug 2007 A1
20070213657 Jennewine et al. Sep 2007 A1
20070227911 Wang et al. Oct 2007 A1
20070232877 He Oct 2007 A1
20070232878 Kovatchev et al. Oct 2007 A1
20070232880 Siddiqui et al. Oct 2007 A1
20070233013 Schoenberg et al. Oct 2007 A1
20070235331 Simpson et al. Oct 2007 A1
20070244383 Talbot et al. Oct 2007 A1
20070249922 Peyser et al. Oct 2007 A1
20070253021 Mehta et al. Nov 2007 A1
20070255321 Gerber et al. Nov 2007 A1
20070255531 Drew Nov 2007 A1
20070258395 Jollota et al. Nov 2007 A1
20070270672 Hayter Nov 2007 A1
20070282299 Hellwig Dec 2007 A1
20070285238 Batra Dec 2007 A1
20070299617 Willis Dec 2007 A1
20080004515 Jennewine et al. Jan 2008 A1
20080004601 Jennewine et al. Jan 2008 A1
20080009692 Stafford Jan 2008 A1
20080017522 Heller et al. Jan 2008 A1
20080018433 Pitt-Pladdy Jan 2008 A1
20080021666 Goode, Jr. et al. Jan 2008 A1
20080029391 Mao et al. Feb 2008 A1
20080030369 Mann et al. Feb 2008 A1
20080033254 Kamath et al. Feb 2008 A1
20080039702 Hayter et al. Feb 2008 A1
20080045824 Tapsak et al. Feb 2008 A1
20080058625 McGarraugh et al. Mar 2008 A1
20080064937 McGarraugh et al. Mar 2008 A1
20080064943 Talbot et al. Mar 2008 A1
20080066305 Wang et al. Mar 2008 A1
20080071156 Brister et al. Mar 2008 A1
20080071157 McGarraugh et al. Mar 2008 A1
20080071158 McGarraugh et al. Mar 2008 A1
20080071328 Haubrich et al. Mar 2008 A1
20080081977 Hayter et al. Apr 2008 A1
20080083617 Simpson et al. Apr 2008 A1
20080086042 Brister et al. Apr 2008 A1
20080086044 Brister et al. Apr 2008 A1
20080086273 Shults et al. Apr 2008 A1
20080097289 Steil et al. Apr 2008 A1
20080102441 Chen et al. May 2008 A1
20080108942 Brister et al. May 2008 A1
20080119703 Brister et al. May 2008 A1
20080119705 Patel et al. May 2008 A1
20080119708 Budiman May 2008 A1
20080139910 Mastrototaro et al. Jun 2008 A1
20080148873 Wang Jun 2008 A1
20080154513 Kovatchev et al. Jun 2008 A1
20080161666 Feldman et al. Jul 2008 A1
20080167543 Say et al. Jul 2008 A1
20080167572 Stivoric et al. Jul 2008 A1
20080172205 Breton et al. Jul 2008 A1
20080177149 Weinert et al. Jul 2008 A1
20080177165 Blomquist et al. Jul 2008 A1
20080183060 Steil et al. Jul 2008 A1
20080183061 Goode et al. Jul 2008 A1
20080183399 Goode et al. Jul 2008 A1
20080188731 Brister et al. Aug 2008 A1
20080188796 Steil et al. Aug 2008 A1
20080189051 Goode et al. Aug 2008 A1
20080194934 Ray et al. Aug 2008 A1
20080194935 Brister et al. Aug 2008 A1
20080194936 Goode et al. Aug 2008 A1
20080194937 Goode et al. Aug 2008 A1
20080194938 Brister et al. Aug 2008 A1
20080195232 Carr-Brendel et al. Aug 2008 A1
20080195967 Goode et al. Aug 2008 A1
20080197024 Simpson et al. Aug 2008 A1
20080200788 Brister et al. Aug 2008 A1
20080200789 Brister et al. Aug 2008 A1
20080200791 Simpson et al. Aug 2008 A1
20080201325 Doniger et al. Aug 2008 A1
20080208025 Shults et al. Aug 2008 A1
20080208113 Damiano et al. Aug 2008 A1
20080214910 Buck Sep 2008 A1
20080214915 Brister et al. Sep 2008 A1
20080214918 Brister et al. Sep 2008 A1
20080228051 Shults et al. Sep 2008 A1
20080228054 Shults et al. Sep 2008 A1
20080234943 Ray et al. Sep 2008 A1
20080235469 Drew Sep 2008 A1
20080242961 Brister et al. Oct 2008 A1
20080242963 Essenpreis et al. Oct 2008 A1
20080255434 Hayter et al. Oct 2008 A1
20080255437 Hayter Oct 2008 A1
20080255438 Saidara et al. Oct 2008 A1
20080255808 Hayter Oct 2008 A1
20080256048 Hayter Oct 2008 A1
20080262469 Brister et al. Oct 2008 A1
20080267823 Wang et al. Oct 2008 A1
20080275313 Brister et al. Nov 2008 A1
20080287761 Hayter Nov 2008 A1
20080287762 Hayter Nov 2008 A1
20080287763 Hayter Nov 2008 A1
20080287764 Rasdal et al. Nov 2008 A1
20080287765 Rasdal et al. Nov 2008 A1
20080287766 Rasdal et al. Nov 2008 A1
20080288180 Hayter Nov 2008 A1
20080288204 Hayter et al. Nov 2008 A1
20080296155 Shults et al. Dec 2008 A1
20080300572 Rankers et al. Dec 2008 A1
20080306368 Goode et al. Dec 2008 A1
20080306434 Dobbles et al. Dec 2008 A1
20080306435 Kamath et al. Dec 2008 A1
20080306444 Brister et al. Dec 2008 A1
20080312518 Jina et al. Dec 2008 A1
20080312841 Hayter Dec 2008 A1
20080312842 Hayter Dec 2008 A1
20080312844 Hayter et al. Dec 2008 A1
20080312845 Hayter et al. Dec 2008 A1
20080314395 Kovatchev et al. Dec 2008 A1
20080319279 Ramsay et al. Dec 2008 A1
20090005665 Hayter et al. Jan 2009 A1
20090005666 Shin et al. Jan 2009 A1
20090006034 Hayter et al. Jan 2009 A1
20090006061 Thukral et al. Jan 2009 A1
20090006133 Weinert et al. Jan 2009 A1
20090012376 Agus Jan 2009 A1
20090012379 Goode et al. Jan 2009 A1
20090018424 Kamath et al. Jan 2009 A1
20090018425 Ouyang et al. Jan 2009 A1
20090030293 Cooper et al. Jan 2009 A1
20090030294 Petisce et al. Jan 2009 A1
20090033482 Hayter et al. Feb 2009 A1
20090036747 Hayter et al. Feb 2009 A1
20090036758 Brauker et al. Feb 2009 A1
20090036760 Hayter Feb 2009 A1
20090036763 Brauker et al. Feb 2009 A1
20090043181 Brauker et al. Feb 2009 A1
20090043182 Brauker et al. Feb 2009 A1
20090043525 Brauker et al. Feb 2009 A1
20090043541 Brauker et al. Feb 2009 A1
20090043542 Brauker et al. Feb 2009 A1
20090045055 Rhodes et al. Feb 2009 A1
20090048503 Dalal et al. Feb 2009 A1
20090054745 Jennewine Feb 2009 A1
20090054748 Feldman et al. Feb 2009 A1
20090054753 Robinson et al. Feb 2009 A1
20090055149 Hayter et al. Feb 2009 A1
20090062633 Brauker et al. Mar 2009 A1
20090062635 Brauker et al. Mar 2009 A1
20090062767 VanAntwerp et al. Mar 2009 A1
20090063402 Hayter Mar 2009 A1
20090076356 Simpson et al. Mar 2009 A1
20090076360 Brister et al. Mar 2009 A1
20090076361 Kamath et al. Mar 2009 A1
20090082693 Stafford Mar 2009 A1
20090085768 Patel et al. Apr 2009 A1
20090099436 Brister et al. Apr 2009 A1
20090105554 Stahmann et al. Apr 2009 A1
20090105560 Solomon Apr 2009 A1
20090105570 Sloan et al. Apr 2009 A1
20090105636 Hayter et al. Apr 2009 A1
20090112478 Mueller, Jr. et al. Apr 2009 A1
20090118589 Ueshima et al. May 2009 A1
20090124877 Goode, Jr. et al. May 2009 A1
20090124878 Goode et al. May 2009 A1
20090124879 Brister et al. May 2009 A1
20090124964 Leach et al. May 2009 A1
20090131768 Simpson et al. May 2009 A1
20090131769 Leach et al. May 2009 A1
20090131776 Simpson et al. May 2009 A1
20090131777 Simpson et al. May 2009 A1
20090137886 Shariati et al. May 2009 A1
20090137887 Shariati et al. May 2009 A1
20090143659 Li et al. Jun 2009 A1
20090143660 Brister et al. Jun 2009 A1
20090143725 Peyser et al. Jun 2009 A1
20090149728 Van Antwerp et al. Jun 2009 A1
20090150186 Cohen et al. Jun 2009 A1
20090156919 Brister et al. Jun 2009 A1
20090156924 Shariati et al. Jun 2009 A1
20090163790 Brister et al. Jun 2009 A1
20090163791 Brister et al. Jun 2009 A1
20090163855 Shin et al. Jun 2009 A1
20090164190 Hayter Jun 2009 A1
20090164239 Hayter et al. Jun 2009 A1
20090164251 Hayter Jun 2009 A1
20090178459 Li et al. Jul 2009 A1
20090182217 Li et al. Jul 2009 A1
20090182517 Gandhi et al. Jul 2009 A1
20090189738 Hermle Jul 2009 A1
20090192366 Mensinger et al. Jul 2009 A1
20090192380 Shariati et al. Jul 2009 A1
20090192722 Shariati et al. Jul 2009 A1
20090192724 Brauker et al. Jul 2009 A1
20090192745 Kamath et al. Jul 2009 A1
20090192751 Kamath et al. Jul 2009 A1
20090198118 Hayter et al. Aug 2009 A1
20090203981 Brauker et al. Aug 2009 A1
20090204341 Brauker et al. Aug 2009 A1
20090216103 Brister et al. Aug 2009 A1
20090234200 Husheer Sep 2009 A1
20090240120 Mensinger et al. Sep 2009 A1
20090240128 Mensinger et al. Sep 2009 A1
20090240193 Mensinger et al. Sep 2009 A1
20090242399 Kamath et al. Oct 2009 A1
20090242425 Kamath et al. Oct 2009 A1
20090247855 Boock et al. Oct 2009 A1
20090247856 Boock et al. Oct 2009 A1
20090247857 Harper et al. Oct 2009 A1
20090253973 Bashan et al. Oct 2009 A1
20090267765 Greene et al. Oct 2009 A1
20090287073 Boock et al. Nov 2009 A1
20090287074 Shults et al. Nov 2009 A1
20090289796 Blumberg Nov 2009 A1
20090294277 Thomas et al. Dec 2009 A1
20090299155 Yang et al. Dec 2009 A1
20090299156 Simpson et al. Dec 2009 A1
20090299162 Brauker et al. Dec 2009 A1
20090299276 Brauker et al. Dec 2009 A1
20100010324 Brauker et al. Jan 2010 A1
20100010331 Brauker et al. Jan 2010 A1
20100010332 Brauker et al. Jan 2010 A1
20100057040 Hayter Mar 2010 A1
20100057041 Hayter Mar 2010 A1
20100057042 Hayter Mar 2010 A1
20100057044 Hayter Mar 2010 A1
20100057057 Hayter et al. Mar 2010 A1
20100063372 Potts et al. Mar 2010 A1
20100064764 Hayter et al. Mar 2010 A1
20100081906 Hayter et al. Apr 2010 A1
20100081909 Budiman et al. Apr 2010 A1
20100081953 Syeda-Mahmood et al. Apr 2010 A1
20100121167 McGarraugh et al. May 2010 A1
20100141656 Krieftewirth Jun 2010 A1
20100160759 Celentano et al. Jun 2010 A1
20100160761 Say et al. Jun 2010 A1
20100168538 Keenan et al. Jul 2010 A1
20100168546 Kamath et al. Jul 2010 A1
20100174266 Estes Jul 2010 A1
20100190435 Cook et al. Jul 2010 A1
20100191085 Budiman Jul 2010 A1
20100191472 Doniger et al. Jul 2010 A1
20100198034 Thomas et al. Aug 2010 A1
20100198142 Sloan et al. Aug 2010 A1
20100204557 Kiaie et al. Aug 2010 A1
20100213057 Feldman et al. Aug 2010 A1
20100230285 Hoss et al. Sep 2010 A1
20100234710 Budiman et al. Sep 2010 A1
20100265073 Harper et al. Oct 2010 A1
20100274515 Hoss et al. Oct 2010 A1
20100277342 Sicurello et al. Nov 2010 A1
20100280441 Willinska et al. Nov 2010 A1
20100280782 Harper et al. Nov 2010 A1
20100312176 Lauer et al. Dec 2010 A1
20100313105 Nekoomaram et al. Dec 2010 A1
20100317952 Budiman et al. Dec 2010 A1
20100324392 Yee et al. Dec 2010 A1
20100326842 Mazza et al. Dec 2010 A1
20110004276 Blair et al. Jan 2011 A1
20110021889 Hoss et al. Jan 2011 A1
20110024043 Boock et al. Feb 2011 A1
20110024307 Simpson et al. Feb 2011 A1
20110027127 Simpson et al. Feb 2011 A1
20110027453 Boock et al. Feb 2011 A1
20110027458 Boock et al. Feb 2011 A1
20110028815 Simpson et al. Feb 2011 A1
20110028816 Simpson et al. Feb 2011 A1
20110029247 Kalathil Feb 2011 A1
20110040163 Telson et al. Feb 2011 A1
20110060530 Fennell Mar 2011 A1
20110077490 Simpson et al. Mar 2011 A1
20110077494 Doniger et al. Mar 2011 A1
20110081726 Berman et al. Apr 2011 A1
20110082484 Saravia et al. Apr 2011 A1
20110105873 Feldman et al. May 2011 A1
20110106126 Love et al. May 2011 A1
20110112696 Yodfat et al. May 2011 A1
20110148905 Simmons et al. Jun 2011 A1
20110152637 Kateraas et al. Jun 2011 A1
20110184268 Taub Jul 2011 A1
20110190603 Stafford Aug 2011 A1
20110191044 Stafford Aug 2011 A1
20110193704 Harper et al. Aug 2011 A1
20110208027 Wagner et al. Aug 2011 A1
20110208155 Palerm et al. Aug 2011 A1
20110213225 Bernstein et al. Sep 2011 A1
20110224523 Budiman Sep 2011 A1
20110257495 Hoss et al. Oct 2011 A1
20110257895 Brauker et al. Oct 2011 A1
20110263958 Brauker et al. Oct 2011 A1
20110288574 Curry et al. Nov 2011 A1
20110319729 Donnay et al. Dec 2011 A1
20110320130 Valdes et al. Dec 2011 A1
20110320167 Budiman Dec 2011 A1
20120010642 Lee et al. Jan 2012 A1
20120078071 Bohm et al. Mar 2012 A1
20120108931 Taub May 2012 A1
20120108934 Valdes et al. May 2012 A1
20120165626 Irina et al. Jun 2012 A1
20120165640 Galley et al. Jun 2012 A1
20120173200 Breton et al. Jul 2012 A1
20120209099 Ljuhs et al. Aug 2012 A1
20120215462 Goode et al. Aug 2012 A1
20120245447 Karan et al. Sep 2012 A1
20130035575 Mayou et al. Feb 2013 A1
20130184547 Taub et al. Jul 2013 A1
20130231541 Hayter et al. Sep 2013 A1
20140121480 Budiman et al. May 2014 A1
20140121488 Budiman May 2014 A1
20140221966 Buckingham et al. Aug 2014 A1
20150216456 Budiman Aug 2015 A1
20150241407 Ou et al. Aug 2015 A1
20160022221 Ou et al. Jan 2016 A1
20170185748 Budiman Jun 2017 A1
Foreign Referenced Citations (34)
Number Date Country
0098592 Jan 1984 EP
0127958 Dec 1984 EP
0320109 Jun 1989 EP
0353328 Feb 1990 EP
0390390 Oct 1990 EP
0396788 Nov 1990 EP
0472411 Feb 1992 EP
0286118 Jan 1995 EP
0867146 Sep 1998 EP
1048264 Nov 2000 EP
1419731 May 2004 EP
0939602 Sep 2004 EP
1850909 Apr 2010 EP
1677668 Jul 2010 EP
WO-1996025089 Aug 1996 WO
WO-1996035370 Nov 1996 WO
WO-1997015227 May 1997 WO
WO-2000049940 Aug 2000 WO
WO-2000059370 Oct 2000 WO
WO-2000074753 Dec 2000 WO
WO-2001052935 Jul 2001 WO
WO-2001054753 Aug 2001 WO
WO-2002016905 Feb 2002 WO
WO-2003076893 Sep 2003 WO
WO-2003082091 Oct 2003 WO
WO-2004060455 Jul 2004 WO
WO-2005065542 Jul 2005 WO
WO-2006024671 Mar 2006 WO
WO-2006081336 Aug 2006 WO
WO-2006085087 Aug 2006 WO
WO-2006110193 Oct 2006 WO
WO-2007097754 Aug 2007 WO
WO-2008001366 Jan 2008 WO
WO-2008086541 Jul 2008 WO
Non-Patent Literature Citations (67)
Entry
Armour, J. C., et al., “Application of Chronic Intravascular Blood Glucose Sensor in Dogs”, Diabetes, vol. 39, 1990, pp. 1519-1526.
Arnold, M. A., et al., “Selectivity Assessment of Noninvasive Glucose Measurements Based on Analysis of Multivariate Calibration Vectors”, Journal of Diabetes Science and Technology, vol. 1, No. 4, 2007, pp. 454-462.
Bennion, N., et al., “Alternate Site Glucose Testing: A Crossover Design”, Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.
Blank, T. B., et al., “Clinical Results From a Non-Invasive Blood Glucose Monitor”, Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.
Boyne, M. S., et al., “Timing of Changes in Interstitial and Venous Blood Glucose Measured With a Continuous Subcutaneous Glucose Sensor”, Diabetes, vol. 52, Nov. 2003, pp. 2790-2794.
Bremer, T. M., et al., “Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies”, Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.
Brooks, S. L., et al., “Development of an On-Line Glucose Sensor for Fermentation Monitoring”, Biosensors, vol. 3, 1987/88, pp. 45-56.
Cass, A. E., et al., “Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose”, Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.
Cheyne, E. H., et al., “Performance of a Continuous Glucose Monitoring System During Controlled Hypoglycaemia in Healthy Volunteers”, Diabetes Technology & Therapeutics, vol. 4, No. 5, 2002, pp. 607-613.
Choleau, C., et al., “Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2. Superiority of the One-Point Calibration Method”, Biosensors and Bioelectronics, vol. 17, No. 8, 2002, pp. 647-654.
Csoregi, E., et al., “Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ‘Wired’ Glucose Oxidase”, Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.
Dassau, E., et al., “Detection of a Meal Using Continuous Glucose Monitoring”, Emerging Treatments and Technologies, vol. 31, No. 2, Feb. 2008, pp. 295-300.
Diabetes Control and Complications Trial Research Group, “The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus,” New England J. Med. vol. 329, 1993, pp. 977-986.
Eren-Oruklu, M., et al., “Estimation of Future Glucose Concentrations with Subject-Specific Recursive Linear Models”, Diabetes Technology & Therapeutics vol. 11(4), 2009, pp. 243-253.
Feldman, B., et al., “A Continuous Glucose Sensor Based on Wired Enzyme™ Technology—Results from a 3-Day Trial in Patients with Type 1 Diabetes”, Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.
Feldman, B., et al., “Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change”, Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.
Guerci, B., et al., “Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs”, Diabetes Care, vol. 26, 2003, pp. 582-589.
Hovorka, R., et al., “Nonlinear Model Predictive Control of Glucose Concentration in Subjects with Type 1 Diabetes”, Physiological Measurement, vol. 55, Jul. 2004, pp. 905-920.
Hyunjin, L., et al., “A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator”, Journal of Diabetes Science and Technology, vol. 3, Issue 5, Sep. 2009, pp. 1082-1090.
Isermann, R., “Supervision, Fault-Detection and Fault-Diagnosis Methods—An Introduction”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 639-652.
Isermann, R., et al., “Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 709-719.
Johnson, P. C., “Peripheral Circulation”, John Wiley & Sons, 1978, pp. 198.
Jungheim, K., et al., “How Rapid Does Glucose Concentration Change in Daily Life of Patients with Type 1 Diabetes?”, 2002, pp. 250.
Jungheim, K., et al., “Risky Delay of Hypoglycemia Detection by Glucose Monitoring at the Arm”, Diabetes Care, vol. 24, No. 7, 2001, pp. 1303-1304.
Kaplan, S. M., “Wiley Electrical and Electronics Engineering Dictionary”, IEEE Press, 2004, pp. 141, 142, 548, 549.
Kovatchev, B. P., et al., “Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors”, Diabetes Care, vol. 27, No. 8, 2004, pp. 1922-1928.
Kovatchev, B. P., et al., “Graphical and Numerical Evaluation of Continuous Glucose Sensing Time Lag”, Diabetes Technology & Therapeutics, vol. 11, No. 3, 2009, pp. 139-143.
Kuure-Kinsey, M., et al., “A Dual-Rate Kalman Filter for Continuous Glucose Monitoring”, Proceedings of the 28th IEEE, EMBS Annual International Conference, New York City, 2006, pp. 63-66.
Lodwig, V., et al., “Continuous Glucose Monitoring with Glucose Sensors: Calibration and Assessment Criteria”, Diabetes Technology & Therapeutics, vol. 5, No. 4, 2003, pp. 573-587.
Lortz, J., et al., “What is Bluetooth? We Explain the Newest Short-Range Connectivity Technology”, Smart Computing Learning Series, Wireless Computing, vol. 8, Issue 5, 2002, pp. 72-74.
Malin, S. F., et al., “Noninvasive Prediction of Glucose by Near-Infrared Diffuse Reflectance Spectoscopy”, Clinical Chemistry, vol. 45, No. 9, 1999, pp. 1651-1658.
Mcgarraugh, G., et al., “Glucose Measurements Using Blood Extracted from the Forearm and the Finger”, TheraSense, Inc., 2001, 16 Pages.
Mcgarraugh, G., et al., “Physiological Influences on Off-Finger Glucose Testing”, Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 367-376.
Mckean, B. D., et al., “A Telemetry-Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors”, IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, 1988, pp. 526-532.
Morbiducci, U, et al., “Improved Usability of the Minimal Model of Insulin Sensitivity Based on an Automated Approach and Genetic Algorithms for Parameter Estimation”, Clinical Science, vol. 112, 2007, pp. 257-263.
Mougiakakou, et al., “A Real Time Simulation Model of Glucose-Insulin Metabolism for Type 1 Diabetes Patients”, Proceedings of the 2005 IEEE, 2005, pp. 298-301.
Panteleon, A. E., et al., “The Role of the Independent Variable to Glucose Sensor Calibration”, Diabetes Technology & Therapeutics, vol. 5, No. 3, 2003, pp. 401-410.
Parker, R., et al., “Robust H∞ Glucose Control in Diabetes Using a Physiological Model”, AIChE Journal, vol. 46, No. 12, 2000, pp. 2537-2549.
Pickup, J., et al., “Implantable Glucose Sensors: Choosing the Appropriate Sensing Strategy”, Biosensors, vol. 3, 1987/88, pp. 335-346.
Pickup, J., et al., “In Vivo Molecular Sensing in Diabetes Mellitus: An Implantable Glucose Sensor with Direct Electron Transfer”, Diabetologia, vol. 32, 1989, pp. 213-217.
Pishko, M. V., et al., “Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels”, Analytical Chemistry, vol. 63, No. 20, 1991, pp. 2268-2272.
Quinn, C. P., et al., “Kinetics of Glucose Delivery to Subcutaneous Tissue in Rats Measured with 0.3-mm Amperometric Microsensors”, The American Physiological Society, 1995, E155-E161.
Roe, J. N., et al., “Bloodless Glucose Measurements”, Critical Review in Therapeutic Drug Carrier Systems, vol. 15, Issue 3, 1998, pp. 199-241.
Sakakida, M., et al., “Development of Ferrocene-Mediated Needle-Type Glucose Sensor as a Measure of True Subcutaneous Tissue Glucose Concentrations”, Artificial Organs Today, vol. 2, No. 2, 1992, pp. 145-158.
Sakakida, M., et al., “Ferrocene-Mediated Needle-Type Glucose Sensor Covered with Newly Designed Biocompatible Membrane”, Sensors and Actuators B, vol. 13-14, 1993, pp. 319-322.
Salehi, C., et al., “A Telemetry-Instrumentation System for Long-Term Implantable Glucose and Oxygen Sensors”, Analytical Letters, vol. 29, No. 13, 1996, pp. 2289-2308.
Schmidtke, D. W., et al., “Measurement and Modeling of the Transient Difference Between Blood and Subcutaneous Glucose Concentrations in the Rat After Injection of Insulin”, Proceedings of the National Academy of Sciences, vol. 95, 1998, pp. 294-299.
Shaw, G. W., et al., “In Vitro Testing of a Simply Constructed, Highly Stable Glucose Sensor Suitable for Implantation in Diabetic Patients”, Biosensors & Bioelectronics, vol. 6, 1991, pp. 401-406.
Shichiri, M., et al., “Glycaemic Control in Pancreatectomized Dogs with a Wearable Artificial Endocrine Pancreas”, Diabetologia, vol. 24, 1983, pp. 179-184.
Shichiri, M., et al., “In Vivo Characteristics of Needle-Type Glucose Sensor—Measurements of Subcutaneous Glucose Concentrations in Human Volunteers”, Hormone and Metabolic Research Supplement Series, vol. 20, 1988, pp. 17-20.
Shichiri, M., et al., “Membrane Design for Extending the Long-Life of an Implantable Glucose Sensor”, Diabetes Nutrition and Metabolism, vol. 2, 1989, pp. 309-313.
Shichiri, M., et al., “Needle-type Glucose Sensor for Wearable Artificial Endocrine Pancreas”, Implantable Sensors for Closed-Loop Prosthetic Systems, Chapter 15, 1985, pp. 197-210.
Shichiri, M., et al., “Telemetry Glucose Monitoring Device With Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals”, Diabetes Care, vol. 9, No. 3, 1986, pp. 298-301.
Shichiri, M., et al., “Wearable Artificial Endocrine Pancreas With Needle-Type Glucose Sensor”, The Lancet, 1982, pp. 1129-1131.
Shults, M. C., et al., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors”, IEEE Transactions on Biomedical Engineering, vol. 41, No. 10, 1994, pp. 937-942.
Steil, G. M., et al., “Determination of Plasma Glucose During Rapid Glucose Excursions with a Subcutaneous Glucose Sensor”, Diabetes Technology & Therapeutics, vol. 5, No. 1, 2003, pp. 27-31.
Steil, G.M., et al., “Closed-Loop Insulin Delivery—the Path of Physiological Glucose Control”, Advanced Drug Delivery Reviews, vol. 56, 2004, pp. 125-144.
Sternberg, R., et al., “Study and Development of Multilayer Needle-Type Enzyme-Based Glucose Microsensors”, Biosensors, vol. 4, 1988, pp. 27-40.
Thompson, M., et al., “In Vivo Probes: Problems and Perspectives”, Clinical Biochemistry, vol. 19, 1986, pp. 255-261.
Turner, A., et al., “Diabetes Mellitus: Biosensors for Research and Management”, Biosensors, vol. 1, 1985, pp. 85-115.
Updike, S. J., et al., “Principles of Long-Term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucose from Inside a Subcutaneous Foreign Body Capsule (FBC)”, Biosensors in the Body: Continuous in vivo Monitoring, Chapter 4, 1997, pp. 117-137.
Velho, G., et al., “Strategies for Calibrating a Subcutaneous Glucose Sensor”, Biomedica Biochimica Acta, vol. 48, 1989, pp. 957-964.
Wilson, G. S., et al., “Progress Toward the Development of an Implantable Sensor for Glucose”, Clinical Chemistry, vol. 38, No. 9, 1992, pp. 1613-1617.
PCT Application No. PCT/U2015/023380, International Search Report and Written Opinion of the International Searching Authority dated Jun. 29, 2015.
European Patent Application No. 15773809.7, Extended European Search Report dated Oct. 25, 2017.
EP, 22178180.0 Extended Search Report, dated Feb. 22, 2023.
EP, 20198318.6 Extended Search Report, dated Jul. 8, 2021.
Related Publications (1)
Number Date Country
20200105397 A1 Apr 2020 US
Provisional Applications (1)
Number Date Country
61972381 Mar 2014 US
Continuations (1)
Number Date Country
Parent 15300711 US
Child 16703196 US